<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Optimal time for initiating antiretroviral therapy (ART) in HIV‐infected, treatment‐naive children aged 2 to 5 years old - Siegfried, N - 2013 | Cochrane Library</title> <meta content="Optimal time for initiating antiretroviral therapy (ART) in HIV‐infected, treatment‐naive children aged 2 to 5 years old - Siegfried, N - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010309.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Optimal time for initiating antiretroviral therapy (ART) in HIV‐infected, treatment‐naive children aged 2 to 5 years old - Siegfried, N - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010309.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010309.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Optimal time for initiating antiretroviral therapy (ART) in HIV‐infected, treatment‐naive children aged 2 to 5 years old" name="citation_title"/> <meta content="Nandi Siegfried" name="citation_author"/> <meta content="nandi.siegfried@gmail.com" name="citation_author_email"/> <meta content="Mary‐Ann Davies" name="citation_author"/> <meta content="School of Public Health and Family Medicine" name="citation_author_institution"/> <meta content="Martina Penazzato" name="citation_author"/> <meta content="Lulu M Muhe" name="citation_author"/> <meta content="World Health Organization" name="citation_author_institution"/> <meta content="Matthias Egger" name="citation_author"/> <meta content="Institute of Social and Preventive Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD010309.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/10/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010309.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010309.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010309.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-HIV Agents [*administration &amp; dosage]; CD4 Lymphocyte Count; Drug Administration Schedule; Drug Therapy, Combination [methods]; HIV Infections [*drug therapy, immunology]; Pilot Projects; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010309.pub2&amp;doi=10.1002/14651858.CD010309.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WcPhDegp";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010309\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010309\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","pt","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010309.pub2",title:"Optimal time for initiating antiretroviral therapy (ART) in HIV\\u2010infected, treatment\\u2010naive children aged 2 to 5 years old",firstPublishedDate:"Oct 10, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane HIV/AIDS Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010309.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010309.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010309.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010309.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010309.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010309.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010309.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010309.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010309.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010309.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>737 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010309.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-sec1-0006"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/appendices#CD010309-sec1-0012"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/table_n/CD010309StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/table_n/CD010309StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Optimal time for initiating antiretroviral therapy (ART) in HIV‐infected, treatment‐naive children aged 2 to 5 years old </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information#CD010309-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Nandi Siegfried</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information#CD010309-cr-0003">Mary‐Ann Davies</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information#CD010309-cr-0004">Martina Penazzato</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information#CD010309-cr-0005">Lulu M Muhe</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information#CD010309-cr-0006">Matthias Egger</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information/en#CD010309-sec1-0014">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 October 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010309.pub2">https://doi.org/10.1002/14651858.CD010309.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010309-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010309-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010309-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010309-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010309-abs-0002">Português</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010309-abs-0001" lang="en"> <section id="CD010309-abs1-0001"> <h3 class="title" id="CD010309-abs1-0001">Background</h3> <p>The use of combination antiretroviral therapy (cART) comprising three antiretroviral medications from at least two classes of drugs is the current standard treatment for HIV infection in adults and children. Current World Health Organization (WHO) guidelines for antiretroviral therapy recommend early treatment regardless of immunologic thresholds or the clinical condition for all infants (less than one years of age) and children under the age of two years. For children aged two to five years current WHO guidelines recommend (based on low quality evidence) that clinical and immunological thresholds be used to identify those who need to start cART (advanced clinical stage or CD4 counts ≤ 750 cells/mm<sup>3</sup> or per cent CD4 ≤ 25%). This Cochrane review will inform the current available evidence regarding the optimal time for treatment initiation in children aged two to five years with the goal of informing the revision of WHO 2013 recommendations on when to initiate cART in children. </p> </section> <section id="CD010309-abs1-0002"> <h3 class="title" id="CD010309-abs1-0002">Objectives</h3> <p>To assess the evidence for the optimal time to initiate cART in treatment‐naive, HIV‐infected children aged 2 to 5 years. </p> </section> <section id="CD010309-abs1-0003"> <h3 class="title" id="CD010309-abs1-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, the AEGIS conference database, specific relevant conferences, <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>, the World Health Organization International Clinical Trials Registry platform and reference lists of articles. The date of the most recent search was 30 September 2012. </p> </section> <section id="CD010309-abs1-0004"> <h3 class="title" id="CD010309-abs1-0004">Selection criteria</h3> <p>Randomised controlled trials (RCTs) that compared immediate with deferred initiation of cART, and prospective cohort studies which followed children from enrolment to start of cART and on cART. </p> </section> <section id="CD010309-abs1-0005"> <h3 class="title" id="CD010309-abs1-0005">Data collection and analysis</h3> <p>Two review authors considered studies for inclusion in the review, assessed the risk of bias, and extracted data on the primary outcome of death from all causes and several secondary outcomes, including incidence of CDC category C and B clinical events and per cent CD4 cells (CD4%) at study end. For RCTs we calculated relative risks (RR) or mean differences with 95% confidence intervals (95% CI). For cohort data, we extracted relative risks with 95% CI from adjusted analyses. We combined results from RCTs using a random effects model and examined statistical heterogeneity. </p> </section> <section id="CD010309-abs1-0006"> <h3 class="title" id="CD010309-abs1-0006">Main results</h3> <p>Two RCTs in HIV‐positive children aged 1 to 12 years were identified. One trial was the pilot study for the larger second trial and both compared initiation of cART regardless of clinical‐immunological conditions with deferred initiation until per cent CD4 dropped to &lt;15%. The two trials were conducted in Thailand, and Thailand and Cambodia, respectively. Unpublished analyses of the 122 children enrolled at ages 2 to 5 years were included in this review. There was one death in the immediate cART group and no deaths in the deferred group (RR 2.9; 95% CI 0.12 to 68.9). In the subgroup analysis of children aged 24 to 59 months, there was one CDC C event in each group (RR 0.96; 95% CI 0.06 to 14.87) and 8 and 11 CDC B events in the immediate and deferred groups respectively (RR 0.95; 95% CI 0.24 to 3.73). In this subgroup, the mean difference in CD4 per cent at study end was 5.9% (95% CI 2.7 to 9.1). One cohort study from South Africa, which compared the effect of delaying cART for up to 60 days in 573 HIV‐positive children starting tuberculosis treatment (median age 3.5 years), was also included. The adjusted hazard ratios for the effect on mortality of delaying ART for more than 60 days was 1.32 (95% CI 0.55 to 3.16). </p> </section> <section id="CD010309-abs1-0007"> <h3 class="title" id="CD010309-abs1-0007">Authors' conclusions</h3> <p>This systematic review shows that there is insufficient evidence from clinical trials in support of either early or CD4‐guided initiation of ART in HIV‐infected children aged 2 to 5 years. Programmatic issues such as the retention in care of children in ART programmes in resource‐limited settings will need to be considered when formulating WHO 2013 recommendations.   </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010309-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010309-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010309-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010309-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/pt#CD010309-abs-0006">Português</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010309-abs-0005" lang="en"> <h3>When is the best time to start antiretroviral therapy in children 2 to 5 years old who have HIV infection? </h3> <p>Antiretroviral combination therapy (cART) has been shown to be effective in slowing down the progression of AIDS and in reducing HIV‐related illnesses and death. In infants and children who are diagnosed with HIV infection and are below two years of age the World Health Organization (WHO) recommends that cART should be started immediately. In children aged 2 to 5 years the WHO 2010 recommendations stated that treatment should be started when the body’s defence system has started to weaken (as indicated by a decline in a child’s CD4 cell count) or complications have occurred. This systematic review was undertaken to help inform the 2013 WHO guidelines which aimed to revise the recommendations of when to start therapy in 2 to 5 years old children. The authors identified two randomised controlled trials (RCTs) that compared immediate with deferred initiation of cART in HIV‐positive children aged 1 to 12 years in Thailand or Cambodia. Additional analyses of 122 children enrolled in the two studies at ages 2 to 5 years were made available for this review. A cohort study from South Africa in HIV‐positive children (median age 3.5 years) starting tuberculosis treatment and ART was also included. Results showed that we still lack enough evidence to determine whether early or late initiation of cART is best in children aged 2 to 5 years. The authors recognized the lack of evidence but highlighted the potential value of simplifying WHO recommendations to start cART in all children below five years with the goal of providing programmatic advantage to treatment programmes in resource‐limited settings. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010309-sec1-0007" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010309-sec1-0007"></div> <h3 class="title" id="CD010309-sec1-0008">Implications for practice</h3> <section id="CD010309-sec1-0008"> <p>There is lack of sufficient evidence from clinical trials to assess whether immediate versus deferred initiation of cART in children aged between 2 and 5 years provides clinical and immunological benefits. </p> <p>While individual level benefits are still unclear, from a programmatic point of view starting cART in all children below 5 years of age may facilitate a more rapid scale‐up of paediatric treatment in resource‐limited settings where coverage remains low. Removing the CD4 barrier to treatment initiation for children less than five years is likely to result in prompter initiation of cART for those eligible children whose treatment is delayed while they wait for CD4 tests and results. In these settings it will nevertheless be critical to prioritise cART to those children with a higher risk of mortality where early ART initiation has proven mortality benefit, such as infants less than one year of age and those with advanced clinical and immunological disease. </p> <p>Based on the evidence in this review, in settings with wide access to CD4 monitoring, good cART coverage and adequate programme retention, CD4‐guided initiation of cART should not be viewed as sub‐optimal standard of care. Adequate pre‐cART clinical follow‐up should be strengthened to ensure prompt recognition of disease progression as soon as this may occur. </p> </section> <h3 class="title" id="CD010309-sec1-0009">Implications for research</h3> <section id="CD010309-sec1-0009"> <p>Large randomised trials assessing morbidity and mortality as well as clinical and immunological outcomes with adequate follow‐up are warranted to provide the evidence base for effective decision making on when to start cART in children aged 24 to 59 months in resource‐limited settings. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD010309-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD010309-sec1-0001"></div> <div class="table" id="CD010309-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged one to 12 years old</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> HIV‐positive, treatment‐naive children aged one to 12 years old <br/> <b>Settings:</b> Thailand and Cambodia<br/> <b>Intervention:</b> IMMEDIATE initiation of cART<br/> <b>Comparison:</b> DEFERRED initiation of cART </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> DEFERRED initiation of cART</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> IMMEDIATE initiation of cART </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/> (0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3</b> <br/> (0.12 to 73.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>343<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CDC Category C disease (number of children)</b> <br/> Follow‐up: 144 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (3 to 105) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.5</b> <br/> (0.25 to 8.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>343<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CDC Category B disease (numbers of children) Peto Odds Ratio</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>189 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>141 per 1000</b> <br/> (83 to 225) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.7</b> <br/> (0.39 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>343<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml (Copy)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>815 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>783 per 1000</b> <br/> (685 to 889) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> <br/> (0.84 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>238<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Weight gain per year in kg</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight gain per year in kg in the intervention groups was<br/> <b>0.1 higher</b> <br/> (0.16 lower to 0.36 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Height gain per year in cm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean height gain per year in cm in the intervention groups was<br/> <b>0.5 higher</b> <br/> (0.2 to 0.8 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Standardized score on Beery VMI at 144 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean standardized score on Beery VMI at 144 weeks in the intervention groups was<br/> <b>1.4 lower</b> <br/> (4.7 lower to 1.9 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patient or population:</b> </p> <p>HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)<br/> <b>Settings:</b> Thailand and Cambodia<br/> <b>Intervention:</b> IMMEDIATE initiation of cART<br/> <b>Comparison:</b> DEFERRED initiation of cART </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comments</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assumed risk</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Corresponding risk</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>DEFERRED initiation of cART</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> As the trials were open‐label neither participants nor caregivers were blinded. However outcome assessors were blinded in the PREDICT trial. Attrition was low in both trials. Information on the randomisation procedure was lacking in <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a>. However, given that this trial is relatively small, we judged the overall risk of bias to be low for the two trials together.<br/> <sup>2</sup> The age group included in the trials ranged from one year to 12 years old and did not focus on the specific population focus of this review: ages 24 to 59 months.<br/> <sup>3</sup> The confidence interval is very large and the event rate very low. There was only one death.<br/> <sup>4</sup> The event rate was very low and the overall sample size is also small.<br/> <sup>5</sup> The trials reported conflicting results and there was substantial unexplained heterogeneity.<br/> <sup>6</sup> The results are from only one trial so consistency cannot be adequately gauged.<br/> <sup>7</sup> The sample size is less than 400 and according to the GRADE approach imprecision is present when continuous outcomes are compared in samples less than 400. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD010309-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subgroup analysis: IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUBGROUP ANALYSIS: IMMEDIATE initiation of cART compared to DEFERRED initiation of cART in HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)<br/> <b>Settings:</b> Thailand and Cambodia<br/> <b>Intervention:</b> SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/> (0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.88</b> <br/> (0.12 to 68.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CDC Category C disease (number of children)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (1 to 236) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> <br/> (0.06 to 14.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CDC Category B disease (numbers of children) Peto Odds Ratio</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>239 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> <br/> (70 to 355) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.64</b> <br/> (0.24 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>789 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>876 per 1000</b> <br/> (679 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.11</b> <br/> (0.86 to 1.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean weight gain per year in kg</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight gain per year in kg in the intervention groups was<br/> <b>0.03 lower</b> <br/> (0.25 lower to 0.19 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean height gain per year in cm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean height gain per year in cm in the intervention groups was<br/> <b>0.3 higher</b> <br/> (0.28 lower to 0.88 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean standardized score on Beery VMI at 144 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean standardized score on Beery VMI at 144 weeks in the intervention groups was<br/> <b>2.3 higher</b> <br/> (4.37 lower to 8.97 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> This is a subgroup analysis within each of the Ananworanich 2009 and <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trials. Randomisation was not conducted within the sub‐group. For <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a>, the proportion of children aged 24 to 59 months in the IMMEDIATE group was 46% (11/24) and in the DEFERRED group it was 89% (17/19). This differential could introduce selection bias.<br/> <sup>2</sup> The sample size of the two subgroups of age‐specific data for 24 to 59 months is 122 and the event rate is very small. The confidence interval is very large.<br/> <sup>3</sup> Randomisation was not conducted within the sub‐group. In the PREDICT trial, the proportion of the overall sample in the subgroup in the IMMEDIATE group was 32% (48/150) and in the DEFERRED group it was 31% (46/150). Although this is balanced, we cannot exclude the possibility of selection bias as this analysis was conducted post hoc.<br/> <sup>4</sup> The sample size of the subgroup of age‐specific data for 24 to 59 months in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial is 94 and the event rate is very small. The confidence interval is large.<br/> <sup>5</sup> Randomisation was not conducted within the sub‐group. In the PREDICT trial, the proportion of the overall sample in the subgroup in the IMMEDIATE group was 32% (48/150) and in the DEFERRED group it was 31% (46/150). In this comparison (children on ART with HIV‐RNA &lt; copies/ml) only those children on ART in the DEFERRED group (19/150) were included so the proportions are very imbalanced.<br/> <sup>6</sup> The sample size of the two subgroups of age‐specific data for 24 to 59 months is small (N = 67). Imprecision is likely to be present.<br/> <sup>7</sup> The sample size is very small. In the GRADE system, imprecision is likely to be present when continuous outcomes are compared in samples less than 400. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010309-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010309-sec1-0002"></div> <section id="CD010309-sec2-0001"> <h3 class="title" id="CD010309-sec2-0001">Description of the condition</h3> <p>The World Health Organization (WHO) estimated that in 2011 there were 2.5 million (2.24 to 2.8 million) people who became newly infected with HIV (<a href="./references#CD010309-bbs2-0022" title="Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2012. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf2012;Accessed 24 May 2013. ">UNAIDS 2012</a>). Of these, an estimated 330 000 [200 000–270 000] were children less than 15 years old. This is a 24% decrease in global figures since 2009 and can largely be attributed to the expansion in access to services for preventing mother‐to‐child transmission of HIV, the primary route of HIV acquisition in children. </p> <p>Sub‐Saharan Africa is disproportionately represented in the epidemic with 69% of the global total of people living with HIV (<a href="./references#CD010309-bbs2-0022" title="Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2012. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf2012;Accessed 24 May 2013. ">UNAIDS 2012</a>). An estimated 90% of the world’s children living with HIV live in sub‐Saharan Africa. At the end of 2011, 54% of the 14.2 million people (adults and children) in need of treatment in low‐ and middle‐income countries were receiving antiretroviral therapy (<a href="./references#CD010309-bbs2-0022" title="Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2012. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf2012;Accessed 24 May 2013. ">UNAIDS 2012</a>). However, in sub‐Saharan Africa, antiretroviral therapy coverage of children in the region is far below the global average, at just 28% (25 ‐ 31%). </p> </section> <section id="CD010309-sec2-0002"> <h3 class="title" id="CD010309-sec2-0002">Description of the intervention</h3> <p>The use of combination antiretroviral therapy (cART) comprising three antiretroviral medications from at least two classes of drugs is the current standard treatment for HIV infection in adults and children (<a href="./references#CD010309-bbs2-0029" title="World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach [2010 revision]. 2010; Vol. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf (Accessed 29 July 2012). ">WHO 2010b</a>). While the availability of cART has changed the course of paediatric HIV infection with a notable reduction in mortality observed over long‐term follow‐up (<a href="./references#CD010309-bbs2-0018" title="PatelK , HernanMA , WilliamsPL , SeegerJD , McIntoshK , VanDykeRB , et al. Long‐term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10‐year follow‐up study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2008;46(4):507‐15. [PUBMED: 18199042] ">Patel 2008</a>), late initiation of cART and poor retention in care remain significant challenges in resource‐limited settings (<a href="./references#CD010309-bbs2-0011" title="FennerL , BrinkhofMW , KeiserO , WeigelR , CornellM , MoultrieH , ProzeskyH , TechnauK , EleyB , VazP , PascoeM , GiddyJ , VanCutsemG , WoodR , EggerM , DaviesMA . Early mortality and loss to follow‐up in HIV‐infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr2010;54(5):542‐532. ">Fenner 2010</a>). Determining the optimal timing to initiate cART in children is challenging for several reasons. As children grow, the organs involved in drug metabolism mature. As a result, the pharmacokinetic environment is dynamic and treatment needs to be adjusted according to age and weight (<a href="./references#CD010309-bbs2-0014" title="HeidariS , MofensonLM , HobbsCV , CottonMF , MarlinkR , KatabiraE . Unresolved antiretroviral treatment management issues in HIV‐infected children. Journal of acquired immune deficiency syndromes (1999)2012;59(2):161‐9. [PUBMED: 22138766] ">Heidari 2012</a>). If malnutrition is present or treatment for co‐infections such as tuberculosis or malaria is required, the pharmacokinetics of drugs may be further altered (<a href="./references#CD010309-bbs2-0014" title="HeidariS , MofensonLM , HobbsCV , CottonMF , MarlinkR , KatabiraE . Unresolved antiretroviral treatment management issues in HIV‐infected children. Journal of acquired immune deficiency syndromes (1999)2012;59(2):161‐9. [PUBMED: 22138766] ">Heidari 2012</a>). Markers of disease progression, such as the CD4 count, are unreliable in young children limiting disease monitoring (<a href="./references#CD010309-bbs2-0020" title="PrendergastAJ , PenazzatoM , CottonM , MusokeP , MulengaV , AbramsEJ , GibbDM . Treatment of Young Children with HIV Infection: Using Evidence to Inform Policymakers. PLoS Medicine2012;9(7):e1001273. doi:10.1371/journal.pmed.1001273. ">Prendergast 2012</a>). Given that treatment is life‐long, the risk of drug resistance is prolonged and the potential for long‐term toxicity exists (<a href="./references#CD010309-bbs2-0014" title="HeidariS , MofensonLM , HobbsCV , CottonMF , MarlinkR , KatabiraE . Unresolved antiretroviral treatment management issues in HIV‐infected children. Journal of acquired immune deficiency syndromes (1999)2012;59(2):161‐9. [PUBMED: 22138766] ">Heidari 2012</a>). Determining the optimal time to initiate cART in children is therefore critical. </p> <p>Current World Health Organization (WHO) guidelines for antiretroviral therapy recommend early treatment regardless of immunologic or clinical thresholds for all infants (less than one year of age) and children under the age of two years (<a href="./references#CD010309-bbs2-0029" title="World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach [2010 revision]. 2010; Vol. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf (Accessed 29 July 2012). ">WHO 2010b</a>). The decision to initiate early treatment in infants was based on the evidence provided by the Children with HIV Early Antiretroviral Therapy trial (CHER) (<a href="./references#CD010309-bbs2-0023" title="ViolariA , CottonMF , GibbDM , BabikerAG , SteynJ , MadhiSA , Jean‐PhilippeP , McIntyreJA , CHER Study Team. Early antiretroviral therapy and mortality among HIV‐infected infants. N Eng J Med2008;359:2233–2244. ">Violari 2008</a>) and supported by a Cochrane review (<a href="./references#CD010309-bbs2-0019" title="PenazzatoM , PrendergastA , TierneyJ , CottonM , GibbD . Effectiveness of antiretroviral therapy in HIV‐infected children under 2 years of age. Cochrane database of systematic reviews (Online)2012;7:CD004772. [PUBMED: 22786492] ">Penazzato 2012</a>). The subsequent extension of this guideline to children under the age of two years was developed with the goal of improving retention and based on the high risk of disease progression and death and the poor predictive value of immunological markers in this age group (<a href="./references#CD010309-bbs2-0020" title="PrendergastAJ , PenazzatoM , CottonM , MusokeP , MulengaV , AbramsEJ , GibbDM . Treatment of Young Children with HIV Infection: Using Evidence to Inform Policymakers. PLoS Medicine2012;9(7):e1001273. doi:10.1371/journal.pmed.1001273. ">Prendergast 2012</a>). </p> <p>For children aged 24 to 59 months (two to five years) current WHO guidelines recommend that clinical and immunological thresholds be used to identify those children aged 24 to 59 months who need to start cART (<a href="./references#CD010309-bbs2-0029" title="World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach [2010 revision]. 2010; Vol. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf (Accessed 29 July 2012). ">WHO 2010b</a>). Specifically, treatment should be initiated for all HIV‐infected children with WHO HIV clinical stages 3 and 4, irrespective of CD4 count. In children aged 24 to 59 months (2 to 5 years in age), cART should be initiated when CD4 counts &lt;= 750 cells/mm3 or %CD4 &lt;= 25%, irrespective of the WHO clinical stage. These recommendations are acknowledged to be based on low or very low quality evidence. </p> </section> <section id="CD010309-sec2-0003"> <h3 class="title" id="CD010309-sec2-0003">Why it is important to do this review</h3> <p>The World Health Organization (WHO) Antiretroviral Therapy Guideline is the main normative cART tool at global level and is used by regional and national programme managers to develop national treatment guidelines. The first guideline was produced in 2002 (<a href="./references#CD010309-bbs2-0024" title="World Health Organization. Scaling up antiretroviral therapy In resource‐limited settings: guidelines for a public health approach. 2002; Vol. http://www.who.int/hiv/pub/prev_care/en/ScalingUp_E.pdf (Accessed 29 July 2012). ">WHO 2002</a>), then revised in 2003 (<a href="./references#CD010309-bbs2-0025" title="World Health Organization. Scaling up antiretroviral therapy in resource‐limited settings:treatment guidelines for a public health approach [2003 revision]. 2003; Vol. http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf (Accessed 29 July 2012). ">WHO 2003</a>). In 2006, and then again in 2010, separate sets of recommendations – one for adults and adolescents (<a href="./references#CD010309-bbs2-0026" title="World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach [2006 revision]. World Health Organization, 2006; Vol. http://www.who.int/hiv/pub/guidelines/artadultguidelines.pdf (Accessed 29 July 2012). ">WHO 2006a</a>; <a href="./references#CD010309-bbs2-0028" title="World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach [2010 revision]. 2010; Vol. http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf (Accessed 29 July 2012). ">WHO 2010a</a>) and another for children (<a href="./references#CD010309-bbs2-0027" title="World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access. Recommendations for a public health approach. 2006; Vol. http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf (Accessed 29 July 2012). ">WHO 2006b</a>; <a href="./references#CD010309-bbs2-0029" title="World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach [2010 revision]. 2010; Vol. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf (Accessed 29 July 2012). ">WHO 2010b</a>) ‐ were published as two guideline documents. In 2011, WHO/UNAIDS established a new initiative,<i>Treatment 2.0</i>, that advocates for the development and expanded use of more simplified, less toxic drug regimens, with high barriers to drug resistance, that require minimal clinical monitoring while maintaining therapeutic efficacy (<a href="./references#CD010309-bbs2-0031" title="World Health Organization. The treatment 2.0 framework for action: catalysing the next phase of treatment, care and support. 2011; Vol. http://whqlibdoc.who.int/publications/2011/9789241501934_eng.pdf (Accessed 2 August 2012). ">WHO 2011b</a>). <i>Treatment 2.0</i> aims to expand access to treatment and applies equally to both adults and children. In this context, revising WHO recommendations will require re‐examining the evidence for when to start cART in infants and children. While a completed Cochrane review has focused on the effectiveness of cART in children aged under two years (<a href="./references#CD010309-bbs2-0019" title="PenazzatoM , PrendergastA , TierneyJ , CottonM , GibbD . Effectiveness of antiretroviral therapy in HIV‐infected children under 2 years of age. Cochrane database of systematic reviews (Online)2012;7:CD004772. [PUBMED: 22786492] ">Penazzato 2012</a>), this Cochrane review will inform the revision of the WHO antiretroviral therapy guidelines specifically for when to initiate cART in children aged two to five years old. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010309-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010309-sec1-0003"></div> <p>To assess the evidence for the optimal time to initiate cART in treatment‐naive, HIV‐infected children aged 24 to 59 months (2 to 5 years old). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010309-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010309-sec1-0004"></div> <section id="CD010309-sec2-0004"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010309-sec3-0001"> <h4 class="title">Types of studies</h4> <p> <ol id="CD010309-lst1-0001"> <li> <p>Randomised controlled trials (RCTs)</p> </li> <li> <p>Prospective cohort studies which followed children from enrolment to start of cARTand for at least a median of one year on cART </p> </li> </ol> </p> <p>Non‐comparative cohort studies in which children are all commenced on cART at enrolment regardless of clinical‐immunological condition were excluded. </p> </section> <section id="CD010309-sec3-0002"> <h4 class="title">Types of participants</h4> <p>Children with confirmed HIV infection (HIV PCR‐positive if diagnosed at age&lt;18 months or HIV ELISA‐positive if diagnosed after 18 months of age) aged between 24 and 59 months (two to five years in age) who are treatment‐naïve (except for exposure to drugs to prevent mother‐to‐child transmission) at commencement of the study. </p> <p>Studies which included the above age group within a larger age range were included. We contacted trial authors to obtain the specific age range 24 to 59 months. </p> <p>Studies in children with tuberculosis and other opportunistic illnesses were included. </p> <p>Studies focused only on infants (less than one year in age) were excluded. These are included in another Cochrane review (<a href="./references#CD010309-bbs2-0019" title="PenazzatoM , PrendergastA , TierneyJ , CottonM , GibbD . Effectiveness of antiretroviral therapy in HIV‐infected children under 2 years of age. Cochrane database of systematic reviews (Online)2012;7:CD004772. [PUBMED: 22786492] ">Penazzato 2012</a>). </p> <p>For RCTs, at study entry, children must <b>not</b> have fulfilled guideline criteria for starting antiretroviral treatment recommended at the time of the study. </p> </section> <section id="CD010309-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>Studies which compare initiating triple cART at different thresholds.</p> <p> <ol id="CD010309-lst1-0002"> <li> <p>In RCTs, the intervention group must have initiated triple cART irrespective of clinical stage or CD4 count (<i>immediate initiation</i> ). The control group must have initiated cART using clinical and immunological criteria to determine the time for initiation (<i>deferred initiation</i>) as recommended at the time of the study. </p> </li> <li> <p>In cohort studies, children starting triple cART at different CD4 percent or CD4 counts must have been compared. Analysis must have included adjustment for time‐dependent confounding and lead‐time bias specifically to evaluate the effect of timing of cART initiation on outcomes. </p> </li> </ol> </p> </section> <section id="CD010309-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <section id="CD010309-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p>Mortality (all‐cause)</p> </section> <section id="CD010309-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010309-lst1-0003"> <li> <p>Clinical occurrence of new HIV‐related events (death or AIDS‐defining illness)</p> </li> <li> <p>Time to event of new HIV‐related events (death or AIDS‐defining illness)</p> </li> <li> <p>Immunological response (change in mean or median CD4+ cell count (mean or median relative change (percent) or mean or median absolute change, compared with baseline, and standard deviation or range as appropriate) </p> </li> <li> <p>Adherence</p> </li> <li> <p>Loss‐to‐follow‐up</p> </li> <li> <p>Virologic response (proportion of patients achieving and maintaining an undetectable viral load, as defined by the investigators; change in HIV‐RNA levels (mean relative change (percent) or mean absolute change, compared with baseline, and standard deviations) </p> </li> <li> <p>HIV drug resistance</p> </li> </ol> </p> <section id="CD010309-sec5-0001"> <h6 class="title">Adverse events</h6> <p>Severe adverse events were reported. If classified according to grade 1 to 4 of the Adverse Event Toxicity Scale, we reported grade 3 and 4 events. Using this scale, grade 1 and 2 denote mild to moderate symptoms, grade 3 denote serious symptoms and grade 4 denote life‐threatening events requiring significant clinical intervention. Grade 5 denotes death (<a href="./references#CD010309-bbs2-0010" title="Division ofAIDS . Table for grading the severity of Adult and Pediatric Adverse Events. Accessed 28 October 2009http://rcc.tech‐res.com/Document/safetyandpharmacovigilance/DAIDS_AE_GradingTable_Clarification_August2009_Final.pdf. ">DAIDS 2009</a>). </p> </section> </section> </section> </section> <section id="CD010309-sec2-0005"> <h3 class="title">Search methods for identification of studies</h3> <p>See: HIV/AIDS Collaborative Review Group search strategy. The search aimed to be comprehensive and included published and unpublished studies and was not limited to any language. </p> <section id="CD010309-sec3-0005"> <h4 class="title">Electronic searches</h4> <p>We developed the search strategy with the assistance of the HIV/AIDS Review Group Trials Search Co‐ordinator. We formulated a comprehensive and exhaustive search strategy in an attempt to identify all relevant randomised controlled trials and cohort studies regardless of language or publication status (published, unpublished, in press, and in progress). Full details of the Cochrane HIV/AIDS Review Group methods and the journals hand‐searched are published in the section on Collaborative Review Groups in<i>The Cochrane Library</i>. </p> <p>For the RCT search, we combined the RCT strategy developed by The Cochrane Collaboration and detailed in the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD010309-bbs2-0016" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org. ">Higgins 2009</a>) in combination with terms specific to initiation of antiretroviral therapy and children. The search was iterative and a number of trial searches were run first as there are no database‐specific terms for 'initiation' of treatment and so we used many free text terms. This increased the yield and hence the search sensitivity but reduced the precision. </p> <p>As there are no validated search strategies for cohort studies, our strategy was informed by the cohort strategy developed by BMJ Clinical Evidence (<a href="http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665076.html" target="_blank">http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665076.html</a>). </p> <p>We searched the following databases:</p> <section id="CD010309-sec4-0003"> <h5 class="title">1. Journal databases</h5> <section id="CD010309-sec5-0002"> <h6 class="title">For RCT Identification:</h6> <p> <ul id="CD010309-lst1-0004"> <li> <p>Medline via Pubmed ‐ see search strategy conducted on 27 June 2012 in <a href="./appendices#CD010309-sec2-0015">Appendix 1</a> </p> </li> <li> <p>EmBase ‐ see search strategy conducted on 27 June 2012 in <a href="./appendices#CD010309-sec2-0016">Appendix 2</a> </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) ‐ see search strategy conducted on 27 June 2012 in <a href="./appendices#CD010309-sec2-0017">Appendix 3</a> </p> </li> </ul> </p> </section> <section id="CD010309-sec5-0003"> <h6 class="title">For cohort identification:</h6> <p> <ul id="CD010309-lst1-0005"> <li> <p>Medline via Pubmed ‐ see search strategy conducted on 11 September 2012 in <a href="./appendices#CD010309-sec2-0018">Appendix 4</a> </p> </li> <li> <p>EmBase ‐ see search strategy conducted on 11 September 2012 in <a href="./appendices#CD010309-sec2-0019">Appendix 5</a> </p> </li> </ul> </p> </section> </section> <section id="CD010309-sec4-0004"> <h5 class="title">2. Conference databases:</h5> <p>We searched the AEGIS database (<a href="http://www.aegis.org" target="_blank">www.aegis.org</a>) on 24 July 2012. <a href="http://www.aegis.org" target="_blank">www.aegis.org</a> contained abstracts from the following major related conferences: 1st‐5th International AIDS Society (IAS) Conference on HIV Pathogenesis and Treatment and Prevention (2001‐2009); 10th‐17th International AIDS Conference (IAC) (1994‐2008); 1st‐16th Conference of Retrovirus and Opportunistic Infections (CROI) (1994‐2009); US National HIV Prevention Conference; 7th‐14th British HIV Association (2001‐2008); and 8th‐9th European AIDS Clinical Society Conference (2001, 2003). </p> <p>AEGIS does not allow for multiple search strings and so, in order to search the database effectively, a separate search was done for relevant terms combined with the term [random*] to identify relevant trials: </p> <p>ANTIRETROVIRAL* AND RANDOM* AND (child* OR infant* OR toddler* OR pediatric* OR paediatric*)</p> <p>The more recent conferences (up to 2012) were covered by searching the conference web‐sites of the International AIDS Society, the International AIDS Conference and the CROI. The abstracts of the 1st, 2nd, 3rd and 4th International Workshop on HIV Pediatrics were hand‐searched in <i>Reviews in Antiviral Therapy &amp; Infectious Diseases</i> where they are published following the conference. </p> </section> <section id="CD010309-sec4-0005"> <h5 class="title">3. Ongoing trials:</h5> <p>To identify ongoing RCTs we searched ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">http://clinicaltrials.gov/</a>) on 9 July 2012 and the World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>) on 12 July 2012. </p> </section> </section> <section id="CD010309-sec3-0006"> <h4 class="title">Searching other resources</h4> <p>We also checked the reference lists of all studies identified by the above methods and examined any systematic reviews, meta‐analyses, or guidelines we identified during the search process for references. </p> <p>We were in close contact with individual researchers working in the field, and policymakers based in inter‐governmental organizations including the World Health Organization (WHO) and UNAIDS. </p> <p>We did not conduct hand‐searching of specific journals other than those searched by the Cochrane HIV/AIDS Review Group and already included in CENTRAL. </p> </section> </section> <section id="CD010309-sec2-0006"> <h3 class="title" id="CD010309-sec2-0006">Data collection and analysis</h3> <section id="CD010309-sec3-0007"> <h4 class="title">Selection of studies</h4> <p>For the RCT search of journal databases, NS and ME read the titles, abstracts and descriptor terms of all downloaded material from the electronic searches to identify potentially eligible reports. Full text articles were be obtained for all citations identified as potentially eligible and NS and ME independently inspected these to establish the relevance of the article according to the pre‐specified criteria. Where there was any uncertainty as to the eligibility of the record, we obtained the full article. </p> <p>NS and ME independently applied the inclusion criteria, and any differences arising were resolved by discussions with the third reviewer, MD. Studies were reviewed for relevance based on study design, types of participants, exposures and outcome measures. </p> <p>For the additional cohort search of journal databases, NS read the titles, abstracts and descriptor terms of all downloaded material from the electronic searches to identify potentially eligible reports. After identification of potentially eligible articles, ME checked these and any uncertainty was discussed and resolved by discussions with the third review author, MD. </p> <p>For all conference abstract searching, NS read the titles, abstracts and descriptor terms of all downloaded material and manually hand‐searched conference abstract books when it was not possible to search the web‐site effectively. NS contacted authors of abstracts to confirm whether the study had been published and/or whether a final report was available. Abstracts which described studies already identified in the electronic searches were linked to these. </p> </section> <section id="CD010309-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>NS independently extracted data into a standardised data extraction form. ME checked the data extraction independently. The following characteristics were extracted from each included study. </p> <p> <ul id="CD010309-lst1-0006"> <li> <p>Administrative details: Trial or study identification number; author(s); published or unpublished; year of publication; number of studies included in paper; year in which study was conducted; details of other relevant papers cited; </p> </li> <li> <p>Details of the study: Study design; type, duration and completeness of follow‐up; country and location of study (e.g. higher‐income vs. lower‐income country); informed consent and ethics approval; </p> </li> <li> <p>Details of participants: Setting, numbers, relevant baseline characteristics including CD4 count and viral load;age range; </p> </li> <li> <p>Details of intervention: CD4 count and age at which treatment was initiated; drug combinations; additional co‐interventions; and </p> </li> <li> <p>Details of outcomes: Mortality; HIV‐related morbidity; HIV‐RNA viral load measurements and proposed levels for suppression, as defined by the authors; clinical disease progression; CD4+ cell counts; adverse events and toxicity. </p> </li> <li> <p>Details of the analysis: For RCTs, details of the type of analysis (intention‐to‐treat or per protocol); for cohort studies, details of the type of adjustment performed in the analysis. </p> </li> </ul> </p> </section> <section id="CD010309-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>For both RCTs and cohort studies, NS and ME independently examined the components of each included study for risk of bias using a standard form. This includes information on the sequence generation, allocation concealment, blinding (participants, personnel and outcome assessor), incomplete outcome data, selective outcome reporting and other sources of bias. The methodological components of the trials were assessed and classified as at a high, low or unclear risk of bias as per the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD010309-bbs2-0016" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org. ">Higgins 2009</a>). Where differences arose, these were resolved by discussions with the third reviewer, MD. </p> <p><i>Sequence generation</i> </p> <p> <ul id="CD010309-lst1-0007"> <li> <p>Adequate: investigators described a random component in the sequence generation process such as the use of random number table, coin tossing, cards or envelops shuffling etc </p> </li> <li> <p>Inadequate: investigators described a non‐random component in the sequence generation process such as the use of odd or even date of birth, algorithm based on the day/date of birth, hospital or clinic record number </p> </li> <li> <p>Unclear: insufficient information to permit judgment of the sequence generation process</p> </li> </ul> </p> <p><i>Allocation concealment</i> </p> <p> <ul id="CD010309-lst1-0008"> <li> <p>Adequate: participants and the investigators enrolling participants cannot foresee assignment, e.g. central allocation; or sequentially numbered, opaque, sealed envelopes. </p> </li> <li> <p>Inadequate: participants and investigators enrolling participants can foresee upcoming assignment, e.g. an open random allocation schedule (e.g. a list of random numbers); or envelopes were unsealed or non­opaque or not sequentially numbered </p> </li> <li> <p>Unclear: insufficient information to permit judgment of the allocation concealment or the method not described </p> </li> </ul> </p> <p><i>Blinding</i> </p> <p> <ul id="CD010309-lst1-0009"> <li> <p>Adequate: blinding of the participants, key study personnel and outcome assessor, and unlikely that the blinding could have been broken. Or lack of blinding unlikely to introduce bias. No blinding in the situation where non‐blinding is not likely to introduce bias. </p> </li> <li> <p>Inadequate: no blinding, incomplete blinding and the outcome is likely to be influenced by lack of blinding </p> </li> <li> <p>Unclear: insufficient information to permit judgment of adequacy or otherwise of the blinding </p> </li> </ul> </p> <p><i>Incomplete outcome data</i> </p> <p> <ul id="CD010309-lst1-0010"> <li> <p>Adequate: no missing outcome data, reasons for missing outcome data unlikely to be related to true outcome, or missing outcome data balanced in number across groups </p> </li> <li> <p>Inadequate: reason for missing outcome data likely to be related to true outcome, with either imbalance in number across groups or reasons for missing data </p> </li> <li> <p>Unclear: insufficient reporting of attrition or exclusions</p> </li> </ul> </p> <p><i>Selective Reporting</i> </p> <p> <ul id="CD010309-lst1-0011"> <li> <p>Adequate: a protocol is available which clearly states the primary outcome as the same as in the final trial report </p> </li> <li> <p>Inadequate: the primary outcome differs between the protocol and final trial report</p> </li> <li> <p>Unclear: no trial protocol is available or there is insufficient reporting to determine if selective reporting is present </p> </li> </ul> </p> <p><i>Control of time‐dependent confounding (cohort studies only)</i> </p> <p>The use of standard regression models for the analysis of cohort studies with time‐updated measurements may result in biased estimates of treatment effects if time‐dependent confounders are present (<a href="./references#CD010309-bbs2-0021" title="RobinsJM , HernanMA , BrumbackB . Marginal structural models and causal inference in epidemiology. Epidemiology2000;11(5):550–560. ">Robins 2000</a>). In cohorts of HIV‐infected patients CD4 cell percentage or CD4 cell counts are measured regularly to assess the patients' eligibility for cART and, once on cART, to monitor therapy. CD4 count is a time‐dependent confounder because it predicts both future cART and outcome, and is influenced by past antiretroviral therapy. In other words, CD4 count is on the causal pathway between treatment and the outcome. </p> <p> <ul id="CD010309-lst1-0012"> <li> <p>Adequate: appropriate methods were used to control for time‐dependent confounding (e.g. marginal structural models) </p> </li> <li> <p>Inadequate: there was no control for time‐dependent confounding</p> </li> <li> <p>Unclear: insufficient reporting to determine whether there was control for time‐dependent confounding </p> </li> </ul> </p> <p><i>Other forms of bias</i> </p> <p> <ul id="CD010309-lst1-0013"> <li> <p>Adequate: there is no evidence of bias from other sources</p> </li> <li> <p>Inadequate: there is potential bias present from other sources (e.g. early stopping of trial, fraudulent activity, extreme baseline imbalance or bias related to specific study design) </p> </li> <li> <p>Unclear: insufficient information to permit judgment of adequacy or otherwise of other forms of bias </p> </li> </ul> </p> </section> <section id="CD010309-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <p>Data analysis was conducted using (RevMan) version 5.1.7.</p> <p>For RCT data, outcome measures for dichotomous data (e.g. death, virological suppression) were calculated as relative risks with 95% confidence intervals. For continuous data (e.g. CD4+ cell counts, HIV‐RNA viral loads) we calculated the mean difference and standard deviation where means were reported. Where medians and ranges were reported, we extracted the data directly from the report. </p> <p>For cohort data, we reported on the adjusted analysis using the estimate of effect reported in the study. Where the adjusted estimate of effect was reported with 95% Confidence Intervals (CI), we calculated the Standard Error in order to enter the data into RevMan, using the following formula for ratio measures: </p> <p>lower limit = ln(lower confidence limit given for HR)</p> <p>upper limit = ln(upper confidence limit given for HR)</p> <p>intervention effect estimate = lnHR</p> <p>SE = (upper limit – lower limit) / 3.92</p> </section> <section id="CD010309-sec3-0011"> <h4 class="title">Unit of analysis issues</h4> <p>We did not anticipate cluster or cross‐over trials, with the potential for unit of analysis issues, being conducted to investigate this question. </p> </section> <section id="CD010309-sec3-0012"> <h4 class="title">Dealing with missing data</h4> <p>Where data was missing or required clarification, we contacted study authors to request additional data. Should this not have been possible, we would have stated explicitly where calculations were based on assumptions regarding missing data. </p> <p>In trials which included participants from within a larger age range, we contacted study authors to obtain the specific age range 24 to 59 months. </p> </section> <section id="CD010309-sec3-0013"> <h4 class="title">Assessment of heterogeneity</h4> <p>Where RCTs were found to be methodologically or clinically comparable, we pooled trial results in a meta‐analysis. As we anticipated the presence of statistical heterogeneity we combined the data using the random effects model throughout. </p> <p>Only one cohort study was included in the review, so it was not applicable to assess heterogeneity. In future updates of this review, where cohort studies are found to be methodologically or clinically comparable, we will pool the results in a meta‐analysis using the generic inverse variance function in RevMan to allow adjusted data to be used in the analysis. As we anticipate heterogeneity due to the likelihood of different analytical techniques and different adjusted variables, we will combine studies using the random effects model. </p> <p>For the RCT meta‐analyses, we formally tested for statistical heterogeneity using the Chi‐square test for statistical homogeneity with a 10% level of significance as the cut‐off. The amount of any statistical heterogeneity was quantified using the I² statistic (<a href="./references#CD010309-bbs2-0015" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21(11):1539‐58. ">Higgins 2002</a>). </p> <p>Where studies do not have combinable outcomes, we provide the data in a narrative form. </p> </section> <section id="CD010309-sec3-0014"> <h4 class="title">Data synthesis</h4> <p>For meta‐analysis of RCTs, we combined the results and calculated the overall relative risk and 95% confidence intervals using the Mantel‐Haenszel random‐effects model. For continuous data, we combined the mean differences to calculate a weighted mean difference and standard deviation, using the inverse‐variance random‐effects model. Peto fixed‐effects models were used in sensitivity analyses. If time‐to‐event data is available in future updates, we will combine the hazard ratios reported in the RCTs using the inverse‐variance random‐effects model. </p> <p>For cohort studies in future updates, we will combine the adjusted estimates of effects using the inverse‐variance random‐effects model. </p> </section> <section id="CD010309-sec3-0015"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We anticipated statistical heterogeneity due to differences between studies conducted in resource‐constrained compared with resource‐rich settings, and planned to present the results according to these sub‐groups should this have been necessary. </p> <p>We performed subgroup analyses restricted to children less than 5 years old who had a CD4 above 25% to best inform the current (2012) WHO guideline processes. </p> </section> <section id="CD010309-sec3-0016"> <h4 class="title">Sensitivity analysis</h4> <p>For RCTs, we planned to explore the effect of study quality on the results by excluding those studies where allocation concealment was unclear or inadequate from the meta‐analysis and assessing the effect of this on the overall results. For cohort studies we planned to examine the effect of adjustments for confounding and in particular confounding by indication. </p> <p>We also conducted meta‐analyses using the Peto Odds Ratio in addition to the RR for those comparisons where the event rate was extremely low. </p> <section id="CD010309-sec4-0006"> <h5 class="title">GRADE assessment</h5> <p><a href="./references#CD010309-bbs2-0012" title="JanBozek , AndrewOxman , OlgerSchunemann . GradePro 2008. Version 3.2 for Windows. GRADE Working Group, 2008, 2008. ">GradePro 2008</a> was used to create Summary of Findings and Evidence Profile tables. GradePro software was developed as part of a larger initiative led by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group. GRADE offers a system for rating quality of evidence in systematic reviews and guidelines and grading strength of recommendations in guidelines (<a href="./references#CD010309-bbs2-0013" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of clinical epidemiology2011;64(4):383‐94. [PUBMED: 21195583] ">Guyatt 2011</a>). Use of GradePro within a Cochrane systematic review facilitates the process of presenting and grading evidence transparently (<a href="http://ims.cochrane.org/revman/other-resources/gradepro/about-gradepro" target="_blank">http://ims.cochrane.org/revman/other‐resources/gradepro/about‐gradepro</a>). </p> <p>In determining the level of evidence for each outcome, both the efficacy results and the assessment of the risk of bias was integrated into a final assessment of the level of evidence and full details of the decision was provided in footnotes. </p> <p> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010309-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010309-sec1-0005"></div> <section id="CD010309-sec2-0007"> <h3 class="title">Description of studies</h3> <section id="CD010309-sec3-0017"> <h4 class="title">Results of the search</h4> <section id="CD010309-sec4-0007"> <h5 class="title">Electronic databases</h5> <section id="CD010309-sec5-0004"> <h6 class="title">1. Journal databases</h6> <section id="CD010309-sec6-0001"> <p><b>RCT studies</b></p> <p>Using the RCT string, the PUBMED search yielded 914 records, the EMBASE search yielded 616 records and the CENTRAL search yielded 127 records. After deduplication using ProCite software, we screened 1475 records of which 54 were identified as potentially eligible RCTs or cohort studies and the full texts were obtained. See <a href="#CD010309-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD010309-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram of database yields using the RCT string" data-id="CD010309-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram of database yields using the RCT string</p> </div> </div> </div> </section> <section id="CD010309-sec6-0002"> <p><b>Cohort studies</b></p> <p>Using the additional cohort string, the PUBMED search yielded 130 records, and the EMBASE search yielded 950 records. These were de‐duplicated electronically using EndNote reference management software, and 33 duplicate records were removed prior to manual checking of the remaining 1047 records. No studies in addition to those already selected for full text review in the RCT string search, were identified. </p> </section> </section> <section id="CD010309-sec5-0005"> <h6 class="title">2. Conference databases</h6> <p>The <a href="http://www.aegis.com" target="_blank">www.aegis.com</a> conference database search yielded 170 records of which 9 abstracts were selected for further assessment. </p> <p>We also searched the conference web‐sites for the following specific conferences using a broad term 'child': </p> <p> <ul id="CD010309-lst1-0014"> <li> <p>International AIDS Society 2009: 305 records identified of which 16 were selected for further assessment </p> </li> <li> <p>International AIDS Society 2011:513 records identified of which 15 were selected for further assessment </p> </li> <li> <p>International AIDS Conference 2012: 115 records identified of which three were selected for further assessment; all relevant sessions reviewed and no additional relevant records identified </p> </li> <li> <p>CROI 2011: 69 records identified of which four were selected for further assessment</p> </li> <li> <p>CROI 2012: 85 records identified of which four were selected for further assessment</p> </li> </ul> </p> <p>NS identified one study (<a href="./references#CD010309-bbs2-0006" title="MunyagwaM , BaisleyK , LevinJ , BrianM , GrosskurthH , MaherD . Mortality of HIV‐infected and uninfected children in a longitudinal cohort in rural south‐west Uganda during 8 years of follow‐up. Tropical medicine &amp; international health : TM &amp; IH2012;17(7):836‐43. [PUBMED: 22591447] ">Munyagwa 2012</a>) from the conference searches which was published after the date the electronic journal database search. This study was excluded after an eligibility assessment of the full text. No other studies identified in the conference searching were in addition to those studies already reviewed in the electronic database searches, or contained data which was relevant to this review after complete data sets were obtained. We contacted a total of five abstract authors to confirm whether their abstracts contained the same data as that reported in publications. </p> </section> <section id="CD010309-sec5-0006"> <h6 class="title">3. Trials Registries</h6> <p>We searched ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">http://clinicaltrials.gov/</a>) on 9 July 2012 and retrieved 300 records of which 9 studies were selected for further assessment. </p> <p>We also searched the World Health Organization International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>) on 12 July 2012 and retrieved 12 records of which one study was selected for further assessment. </p> <p>None of the 21 studies assessed met our inclusion criteria. in future updates we will capture the details of studies meeting our inclusion criteria under Characteristics of ongoing studies. </p> </section> </section> <section id="CD010309-sec4-0008"> <h5 class="title">Searching other resources</h5> <p>To supplement the electronic searching for conference databases, we searched the following books of conference abstracts manually during August and September 2012: </p> <p> <ul id="CD010309-lst1-0015"> <li> <p>CROI 2009: 2 records were identified for further assessment</p> </li> <li> <p>CROI 2010: 2 records were identified for further assessment</p> </li> <li> <p>1st International Workshop on HIV Pediatrics (157 abstracts in total): 13 records identified for further assessment </p> </li> <li> <p>2nd International Workshop on HIV Pediatrics (123 abstracts in total); 10 records identified for further assessment </p> </li> <li> <p>3rd International Workshop on HIV Pediatrics (186 abstracts in total): 10 records identified for further assessment </p> </li> <li> <p>4th International Workshop on HIV Pediatrics (200 abstracts in total); 5 records identified for further assessment </p> </li> </ul> </p> <p>Through discussions with experts in the field and prior discussions at conferences, we were aware of the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial which was published during the conduct of this review. This study was reported in several of the above abstracts which we selected for further assessment. No additional eligible studies were identified in this way. </p> </section> </section> <section id="CD010309-sec3-0018"> <h4 class="title">Included studies</h4> <section id="CD010309-sec4-0009"> <h5 class="title">RCTs</h5> <p>Following detailed eligibility assessment, two RCTs were identified as eligible (<a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a>; <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a>) from the database searches. Additional searches of conferences and the trials registries identified further abstracts which referred to these trials, but no additional RCTs were identified in this way. </p> <p>Details of the included studies are reported in the table <a href="./references#CD010309-sec2-0022" title="">Characteristics of included studies</a>. </p> <p>In summary, two RCTs have evaluated the timing of initiating cART in HIV‐positive children aged 1 to 12 years, with CD4% between 15 and 24%, and no CDC clinical stage C disease. cART was initiated immediately on enrolment (IMMEDIATE group) or deferred until the CD4% dropped to &lt; 15% (DEFERRED group). The first trial (<a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a>) commenced in December 2001 and was designed as a small feasibility study prior to the conduct of the larger trial which commenced in March 2006 (<a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a>). Both trials were conducted in south‐east Asia: <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> was conducted in Thailand with a sample size of 43 and <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> was conducted in Thailand and Cambodia with a sample size of 300. </p> <p>Of note, no trials have been conducted only in the specific age group this review covers, viz. 24 to 59 months. In the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial, the median age of participants was 4.8 years (IQR: 2.7 to 6.6) and in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, 59% (88/150) and 55% (83/150) of children were aged 1 to 6 years in the IMIMEDIATE and DEFERRED group respectively. </p> </section> <section id="CD010309-sec4-0010"> <h5 class="title">Cohorts</h5> <p>Following detailed eligibility assessment, several cohort studies were selected for further assessment of the full‐text. After discussions between the co‐authors, only one cohort study was deemed eligible (<a href="./references#CD010309-bbs2-0003" title="YotebiengM , VanRieA , MoultrieH , ColeSR , AdimoraA , BehetsF , et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (London, England)2010;24(9):1341‐9. [PUBMED: 20559039] ">Yotebieng 2010</a>). See the details of the study in the table <a href="./references#CD010309-sec2-0022" title="">Characteristics of included studies</a>. </p> <p>This study was an observational cohort of prospectively collected routine data of children infected with tuberculosis (TB) and compared the timing of initiation of cART using the number of days since TB treatment was initiated, rather than based on CD4 cell count or percentage. The cohort study commenced in April 2004 and took place in a paediatric clinic attached to a tertiary hospital in Soweto, South Africa. </p> <p>The study included 573 children aged 1 to 15 years with a median age of 3.5 years (IQR: 1.4 ‐ 6.8). The median length of follow‐up was 9.6 months (IQR: 1.9 to 23.1) which was less than the median follow‐up of one year stipulated in our review criteria for study eligibility. However, after discussion among the co‐authors, we determined that given the paucity of data on ART initiation in TB populations, we would include the study in the current review. </p> </section> </section> <section id="CD010309-sec3-0019"> <h4 class="title">Excluded studies</h4> <p>After assessing the full‐text articles 51 studies were excluded for the reasons detailed in <a href="#CD010309-fig-0001">Figure 1</a>. </p> </section> </section> <section id="CD010309-sec2-0008"> <h3 class="title">Risk of bias in included studies</h3> <p>The detail of the risk of bias are presented in the <a href="./references#CD010309-sec2-0022" title="">Characteristics of included studies</a> and the graphical summary of the risk of bias is represented in <a href="#CD010309-fig-0002">Figure 2</a>; <a href="#CD010309-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD010309-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010309-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD010309-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010309-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD010309-sec3-0020"> <h4 class="title">Allocation</h4> <section id="CD010309-sec4-0011"> <h5 class="title">RCTs</h5> <p>In <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> we were unable to assess the risk of bias in the randomisation and allocation procedures due to a lack of reporting and judged the risk of bias as unclear. We judged the risk of bias due to selection bias as low for the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial as the random sequence was generated by a computer and allocation was done centrally. </p> </section> <section id="CD010309-sec4-0012"> <h5 class="title">Cohort</h5> <p>As <a href="./references#CD010309-bbs2-0003" title="YotebiengM , VanRieA , MoultrieH , ColeSR , AdimoraA , BehetsF , et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (London, England)2010;24(9):1341‐9. [PUBMED: 20559039] ">Yotebieng 2010</a> is a cohort study, allocation was not done randomly. The study is therefore at high risk of selection bias but it was analysed in a way that will have reduced bias (mimicking a randomised trial ‐ see other sources of bias below). </p> </section> </section> <section id="CD010309-sec3-0021"> <h4 class="title">Blinding</h4> <section id="CD010309-sec4-0013"> <h5 class="title">RCTs</h5> <p>Both trials were open‐label and thus neither participants and their caregivers nor personnel were blinded, potentially introducing a high risk of performance bias. </p> <p>In the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial we were not able to determine whether outcomes were assessed in a blinded manner and we rated the risk of bias as unclear. In <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a>, the primary outcomes were assessed by an independent committee blinded to allocation and the risk of detection bias was low. </p> </section> <section id="CD010309-sec4-0014"> <h5 class="title">Cohort</h5> <p>The personnel and caregivers were not blinded to whether the children were receiving cART or not and we judged the risk of performance bias as high. </p> <p>Although the authors do not report on blinding for the two primary outcomes of death and virological suppression (in those patients receiving cART) or on how death was confirmed, we judged the lack of blinding as unlikely to result in a high risk of detection bias given the nature of these outcomes </p> </section> </section> <section id="CD010309-sec3-0022"> <h4 class="title">Incomplete outcome data</h4> <section id="CD010309-sec4-0015"> <h5 class="title">RCTs</h5> <p>Both trials had high follow‐up rates (≤ 10%) and risk of attrition bias was low.</p> </section> <section id="CD010309-sec4-0016"> <h5 class="title">Cohort</h5> <p>The overall loss to follow‐up was 13% and the study used time‐to‐event analysis to address this. The authors also report that the children lost to follow‐up did not differ from those remaining in care in any of the baseline characteristics or timing of ART initiation and we judged the risk of bias to be low. </p> </section> </section> <section id="CD010309-sec3-0023"> <h4 class="title">Selective reporting</h4> <section id="CD010309-sec4-0017"> <h5 class="title">RCTs</h5> <p>We were able to compare the protocol in <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a> with the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> report and no selective reporting was noted with a low risk of bias. We were not able to identify the protocol for <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> and rated the risk of bias as unclear. </p> </section> <section id="CD010309-sec4-0018"> <h5 class="title">Cohort</h5> <p>We were not able to compare the protocol with the results and rated the risk of bias as unclear. </p> </section> </section> <section id="CD010309-sec3-0024"> <h4 class="title">Other potential sources of bias</h4> <section id="CD010309-sec4-0019"> <h5 class="title">RCTs</h5> <p>We did not identify other potential sources of bias in either trial.</p> </section> <section id="CD010309-sec4-0020"> <h5 class="title">Cohort</h5> <p>For cohort studies we assessed whether the analysis had appropriately controlled for time‐dependent confounding. In the <a href="./references#CD010309-bbs2-0003" title="YotebiengM , VanRieA , MoultrieH , ColeSR , AdimoraA , BehetsF , et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (London, England)2010;24(9):1341‐9. [PUBMED: 20559039] ">Yotebieng 2010</a> cohort the authors made use of inverse probability‐of‐treatment and censoring (IPTC) weighting of marginal structural models, an appropriate statistical analysis to control for time‐dependent confounding, which mimics a randomised trial. We rated the risk as low. </p> </section> </section> </section> <section id="CD010309-sec2-0009"> <h3 class="title" id="CD010309-sec2-0009">Effects of interventions</h3> <p>See: <a href="./full#CD010309-tbl-0001"><b>Summary of findings for the main comparison</b> IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged one to 12 years old</a>; <a href="./full#CD010309-tbl-0002"><b>Summary of findings 2</b> Subgroup analysis: IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)</a> </p> <p>We present the outcomes as these were reported in the study reports and include any additional outcomes where these were not included in our outcomes list in the protocol. As the two trials were conducted in similar populations we did not consider clinical or methodological heterogeneity as barriers to meta‐analysis. Therefore we have combined the results from both trials in meta‐analyses using the random effects model where possible. Where indicated, we conducted further sensitivity analyses using different analytical models. We report the results from our RevMan calculations and provide narrative results where it was not possible to extract the data for further analysis e.g. where adjusted analyses were conducted or where medians were reported. </p> <p>The authors of both trials provided unpublished age‐specific data for the 24 to 59 month age group for outcomes determined to be most critical for guideline development, and we present these results as a post hoc subgroup analysis and report on this in the text. </p> <p>For the results from the cohort study, we present the adjusted and weighted results and not the crude results due to the inherent confounding present in unadjusted analyses. </p> <section id="CD010309-sec3-0025"> <h4 class="title">Mortality</h4> <p>In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, one death was observed in the IMMEDIATE group . Due to the low number of events the results are unlikely to be meaningful (see <a href="./references#CD010309-fig-00101" title="">Analysis 1.1</a>). This death was in the IMMEDIATE group in the 24 to 59 month age group. See <a href="./references#CD010309-fig-00201" title="">Analysis 2.1</a>. </p> <p>In the <a href="./references#CD010309-bbs2-0003" title="YotebiengM , VanRieA , MoultrieH , ColeSR , AdimoraA , BehetsF , et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (London, England)2010;24(9):1341‐9. [PUBMED: 20559039] ">Yotebieng 2010</a> cohort study, death was compared in three different time periods: 1) cART initiation after 15 days following TB treatment compared with within 15 days; 2) cART initiation after 30 days (1 month) following TB treatment compared with within 30 days (1 month); and 3) cART initiation after 60 days following TB treatment compared within 60 days. </p> <p> <ul id="CD010309-lst1-0016"> <li> <p>More than 15 days vs less than 15 days:</p> <ul id="CD010309-lst2-0001"> <li> <p>The authors calculated a weighted HR accounting for time‐dependent level of immuno‐suppression, viral load, weight‐for‐age Z score and age at TB treatment initiation. The reported weighted HR was 0.82 (95% CI: 0.48, 1.41). See <a href="./references#CD010309-fig-00301" title="">Analysis 3.1</a>. (note that the calculated 95% CI in RevMan differs very slightly from the 95% CI reported by the authors). </p> </li> </ul> </li> <li> <p>More than 30 days vs less than 30 days:</p> <ul id="CD010309-lst2-0002"> <li> <p>The authors calculated a weighted HR of 0.86 (95% CI: 0.46, 1.60). Weighting accounted for time‐dependent level of immuno‐suppression, viral load, weight‐for‐age Z score and age at TB treatment initiation. See <a href="./references#CD010309-fig-00301" title="">Analysis 3.1</a> (note that the calculated 95% CI in RevMan differs very slightly from the reported 95% CI). </p> </li> </ul> </li> <li> <p>More than 60 days vs less than 60 days:</p> <ul id="CD010309-lst2-0003"> <li> <p>The authors calculated a weighted HR of 1.32 (95% CI: 0.55, 3.16). Weighting accounted for time‐dependent level of immuno‐suppression, viral load, weight‐for‐age Z score and age at TB treatment initiation. See <a href="./references#CD010309-fig-00301" title="">Analysis 3.1</a> (note that the calculated 95% CI in RevMan differs very slightly from the reported 95% CI). </p> </li> </ul> </li> </ul> </p> <p>From <a href="./references#CD010309-fig-00301" title="">Analysis 3.1</a> a dose‐response gradient can be observed in the increasing HR values. This indicates that deferring cART initiation to later than 15 days after commencing TB treatment was protective against death but this effect was reduced at 30 days. Deferred initiation became potentially harmful if cART was deferred beyond 60 days. None of these HR were statistically significantly different from 1. </p> <p>NOTE: The denominators in <a href="./references#CD010309-fig-00301" title="">Analysis 3.1</a> vary with each cut‐off time period due to censoring (the authors provide an example of a child whose follow‐up ended 25 days after TB initiation and prior to cART who would be classified for the 15 days cut‐off but not for the 30 or 60 day cut‐off periods). </p> </section> <section id="CD010309-sec3-0026"> <h4 class="title">Morbidity</h4> <section id="CD010309-sec4-0021"> <h5 class="title">AIDS‐free survival</h5> <p>In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, the authors report an intention‐to‐treat analysis of AIDS‐free survival rates for all children at week 144 using the Kaplan‐Meier product limit method and the IMMEDIATE group as the reference group. At week 144 AIDS‐free survival rates in intention to treat analysis were 98.7% (95%CI: 94.7, 99.7%) in the DEFERRED group and 97.9% (95% CI: 93.7, 99.3%) in the IMMEDIATE group (Log rank p=0.6). In per protocol analysis, AIDS‐free survival rates at week 144 were 98.7% (95% CI: 94.7, 99.7%) in the DEFERRED group and 98.6% (95% CI 94.5‐99.6%) in the IMMEDIATE group (Log rank p=0.96). </p> </section> <section id="CD010309-sec4-0022"> <h5 class="title">CDC category C disease</h5> <p>No children in the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial developed CDC Category C disease. In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial three children in the IMMEDIATE group developed CDC Category C disease (<i>Pneumocystis jiroveci</i> pneumonia (1); Pneumonia/Sepsis leading to death (1); Disseminated Penicilliosis (1)) and two children developed Category C disease in the DEFERRED group (Oesaphageal Candidiasis (1); Extrapulmonary Tuberculosis (1)). We calculated the relative risk (RR) in RevMan (See <a href="./references#CD010309-fig-00102" title="">Analysis 1.2</a>). The RR was 1.50 (95% CI: 0.25, 8.85; p = 0.65). The authors report CDC category C events incidence as 4.9 per 1000 person‐years of follow‐up (PYFU) in the DEFERRED group and 7.6 per 1000 PYFU in the IMMEDIATE group (unadjusted hazard ratio (HR) = 0.7 (95%CI: 0.1, 3.9; p=0.6) and HR adjusted for age and gender = 0.8 (95%CI: 0.1, 4.6; p=0.8). </p> <p>In the subgroup analysis of the 24 to 59 month age group in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, the RR was 0.96 (95% CI: 0.06, 14.87; p = 0.98). See <a href="./references#CD010309-fig-00202" title="">Analysis 2.2</a>. </p> </section> <section id="CD010309-sec4-0023"> <h5 class="title">CDC Category B disease</h5> <p>We combined the data from both trials for children in all age groups using the random effects model. The RR was 1.42 (95% CI: 0.14, 14.28; p = 0.77; see <a href="./references#CD010309-fig-00103" title="">Analysis 1.3</a>). We categorised the pulmonary TB observed in the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial as CDC Category B disease. The results show that there was a greater likelihood of CDC Category B diseases in the IMMEDIATE group than in the DEFERRED group but that this was not statistically significant. However, statistical heterogeneity was present (Chi² = 2.84, df = 1; p = 0.09) with the I² = 65% indicating that there was substantial heterogeneity not explained by chance. </p> <p>We conducted a sensitivity analysis and re‐analysed the data using the Peto Odds Ratio (POR) because it is the recommended approach for uncommon events, particularly when there are trials with zero events as in the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial. The POR was 0.70 (95% CI: 0.39, 1.24; p = 0.22; see <a href="./references#CD010309-fig-00104" title="">Analysis 1.4</a>). Note that the weighting for <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> changes from 33.5% to 7.8% in this analysis. These results indicate that the odds of developing CDC Category B events was 0.7 times lower in the IMMEDIATE group than in the DEFERRED group. However, heterogeneity was present (Chi² = 5.22, df = 1; p = 0.02) with an I² = 81%. </p> <p>The high level of heterogeneity would suggest that these results should not be combined in a meta‐analysis, although the second analysis which down‐weights the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial is probably more appropriate. The authors of <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> report that CDC class B incidence was 110 (95%CI: 80, 147) events per 1000 PYFU in the DEFERRED group and 88 (95%CI: 61,122) events per 1000 PYFU in the IMMEDIATE group (incidence rate ratio (IRR) = 1.25; 95% CI: 0.8, 1.9; p = 0.3). Therefore, early treatment of 45 children for a year rather than deferring treatment until CD4 falls to below 15% would prevent 1 CDC category B event. This result is more consistent with that of <a href="./references#CD010309-fig-00104" title="">Analysis 1.4</a> (note the reference or control group is the IMMEDIATE group in the results reported from the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, and in <a href="./references#CD010309-fig-00104" title="">Analysis 1.4</a> the reference group is the DEFERRED group). </p> <p>In the meta‐analysis of the subgroups of 24 to 59 month age groups, we performed the identical sensitivity analysis to that reported above. The result was similar to that of all age groups (POR = 0.76; 95% CI: 0.29, 2.02; p = 0.59). See <a href="./references#CD010309-fig-00204" title="">Analysis 2.4</a>. </p> </section> <section id="CD010309-sec4-0024"> <h5 class="title">Pulmonary TB</h5> <p>The incidence of pulmonary TB was low in both trials. We combined the results for children of all age groups in a random effects meta‐analysis (see <a href="./references#CD010309-fig-00105" title="">Analysis 1.5</a>). The risk of developing pulmonary TB was greater in the IMMEDIATE group than the DEFERRED group but the difference was not statistically significant (RR = 3.21, 95% CI: 0.52, 19.89; p = 0.21). Heterogeneity was minimal (Chi² = 0.99, df = 1; p = 0.32); with an I² = 0% indicating no important statistical heterogeneity. </p> <p>Given the low number of events we again conducted a sensitivity analysis using the Peto Odds Ratio and found similar results (POR: 3.49, 95% CI: 0.67, 18.13; p = 0.14) with likely unimportant heterogeneity (Chi² = 1.20, df = 1; p = 0.27; I² = 17%). The authors of the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial report that the four TB events were not considered to be the result of immune reconstitution syndromes due to the large gap between ART initiation and TB diagnosis (median time of 60 weeks with range 48 to 72 weeks). All four children responded well to anti‐TB treatment. </p> <p>In the meta‐analysis of the subgroups of 24 to 59 month age groups, one case of pulmonary TB was observed in each group (RR = 1.19; 95% CI: 0.19, 7.27; p = 0.85) with low heterogeneity (Chi² = 1.36, df = 1; p = 0.24; I² = 26%). </p> </section> <section id="CD010309-sec4-0025"> <h5 class="title">Median time before development of CDC B or C events</h5> <p>Both trials reported on the median time before development of either CDC B or C events for children of all age groups. In the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial, events developed in the IMMEDIATE group after a median of 60 (IQR: 48 ‐ 72) weeks and no events developed in the DEFERRED group. In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, events developed after a median of 9 (IQR: 4 ‐ 30) weeks since enrolment in the IMMEDIATE group compared with a median of 57 (IQR: 34 ‐ 101) weeks in the DEFERRED group. </p> </section> </section> <section id="CD010309-sec3-0027"> <h4 class="title">Virological and immunological response</h4> <section id="CD010309-sec4-0026"> <h5 class="title">Virological suppression</h5> <section id="CD010309-sec5-0007"> <h6 class="title">1. Proportion of children on cART with HIV‐RNA &lt; 50 copies/ml</h6> <p>Both trials provided data on the proportion of children of all age groups on cART with HIV‐RNA &lt; 50 copies/ml, but the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial restricted analyses to children on first‐line cART for at least 48 weeks whereas this was not the case in the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial so we cannot be certain that the time periods are identical. We combined the data in a random effects meta‐analysis (RR = 0.96; (95% CI: 0.84, 1.09; p = 0.52; see <a href="./references#CD010309-fig-00107" title="">Analysis 1.7</a>). From these data it is evident that the probability of a viral load &lt; 50 copies/ml was similar in the IMMEDIATE group and the DEFERRED group. There was no statistical heterogeneity (Chi² = 0.29, df = 1; p = 0.59; I² = 0%). </p> <p>In the subgroup analysis of the 24 to 59 month age group in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, the results were similar to that for all age groups (RR = 1.11; 95%CI: 0.86, 1.43; p = 0.43). </p> </section> <section id="CD010309-sec5-0008"> <h6 class="title">2. Proportion of children on cART with HIV‐RNA &lt; 400 copies/ml</h6> <p>The <a href="./references#CD010309-bbs2-0003" title="YotebiengM , VanRieA , MoultrieH , ColeSR , AdimoraA , BehetsF , et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (London, England)2010;24(9):1341‐9. [PUBMED: 20559039] ">Yotebieng 2010</a> cohort study assessed virologic suppression in 70% (324/461) of children who initiated cART and who had at least one viral load measurement after cART initiation. The results were analysed in the same three time‐periods as for mortality. </p> <p> <ul id="CD010309-lst1-0017"> <li> <p>More than 15 days vs less than 15 days:</p> <ul id="CD010309-lst2-0004"> <li> <p>The authors calculated an adjusted HR which accounted for baseline differences. The reported adjusted HR was 0.98 (95% CI: 0.76, 1.26; see <a href="./references#CD010309-fig-00302" title="">Analysis 3.2</a>). </p> </li> </ul> </li> <li> <p>More than 30 days vs less than 30 days:</p> <ul id="CD010309-lst2-0005"> <li> <p>The authors calculated a HR adjusted for baseline differences of 0.95 (95% CI: 0.73, 1.23; see <a href="./references#CD010309-fig-00302" title="">Analysis 3.2</a>). </p> </li> </ul> </li> <li> <p>More than 60 days vs less than 60 days:</p> <ul id="CD010309-lst2-0006"> <li> <p>The authors calculated an adjusted HR of 0.84 (95% CI: 0.61, 1.15; see <a href="./references#CD010309-fig-00302" title="">Analysis 3.2</a>). </p> </li> </ul> </li> </ul> </p> <p>As for the analysis of death (see <a href="./references#CD010309-fig-00301" title="">Analysis 3.1</a>) we noted a dose‐response gradient in the hazard ratios for virologic suppression: children were less likely to achieve virologic suppression for each increment in deferred time to cART initiation, however, none of the HRs were statistically significantly different from 1. </p> </section> </section> <section id="CD010309-sec4-0027"> <h5 class="title">Median viral load at study end</h5> <p>The authors of the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial report on the median viral load at the end of the study (median of 134 weeks follow‐up) for children of all age groups. In the IMMEDIATE group, there was a statistically significantly lower median viral load of 1.7 log<sub>10</sub> copies/ml (IQR 1.7 – 2.5) compared with the DEFERRED group viral load of 3.1 log<sub>10</sub> copies/ml (IQR 1.7 – 4.5; p = 0.039). The median change in viral load at study end was ‐2.8 log<sub>10</sub> copies/ml (IQR ‐3.4 to ‐1.9) in the IMMEDIATE group compared with ‐1.8 log<sub>10</sub> copies/ml (IQR: ‐3.2 to ‐0.3). The p value for this difference was p = 0.079. </p> </section> <section id="CD010309-sec4-0028"> <h5 class="title">Median CD4% at study end</h5> <p>For children of all age groups, the authors of <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> reported that at the end of the study (median of 134 weeks follow‐up), the median CD4% in the IMMEDIATE group was statistically significantly higher at 31% (IQR: 24 ‐ 39) compared with the DEFERRED group of median CD4% 23% (IQR: 17 ‐ 31; p = 0.032). The median CD4% change was 13.5% (IQR: 4 ‐ 18) in the IMMEDIATE group compared with 3% (IQR: ‐2 to 13) in the DEFERRED group (p = 0.012). </p> </section> <section id="CD010309-sec4-0029"> <h5 class="title">Mean CD4% and change in CD4% at week 144</h5> <p>In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, the authors report a mean CD4% at week 144 of 33.2% (SD: 6.4) in the IMMEDIATE group compared with a mean CD4% of 24.8% (SD: 7.4) in the DEFERRED group for children of all age groups. We calculated the mean difference (see <a href="./references#CD010309-fig-00109" title="">Analysis 1.9</a>) as 8.40% (95% CI: 6.83, 9.97; p &lt; 0.00001). At the end of the study the mean CD4% in the IMMEDIATE group was thus higher than in the DEFERRED group. The authors also conducted a Kaplan‐Meier analysis to determine the probability of achieving CD4% ≥30% at week 96. The probability was 0.83 (95% CI 0.77‐0.89) in the IMMEDIATE group and 0.74 (95% CI 0.62‐0.84) in the DEFERRED group (p &lt; 0.001) indicating that the children in the IMMEDIATE group were more likely to achieve CD4% ≥30% at week 96. In the subgroup analysis of the 24 to 59 month age group in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, the mean CD4% at the end of the trial was 5.9% higher in the IMMEDIATE group than in the DEFERRED group (95%CI: 2.74, 9.06; p = 0.0003; see <a href="./references#CD010309-fig-00207" title="">Analysis 2.7</a>). </p> </section> <section id="CD010309-sec4-0030"> <h5 class="title">Proportion of children with CD4% &lt;15% at study end</h5> <p>In <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> no children in the IMMEDIATE group had a CD4% &lt;15% at study end and three children did in the DEFERRED group ‐ all of whom had less than four week of cART. In <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a>, using the Last Observation Carried Forwards (LOCF) approach, one child in the IMMEDIATE group and nine children in the DEFERRED group had a CD4% &lt;15% at study end (unpublished data). The meta‐analysis of the combined data showed that fewer children in the IMMEDIATE group had CD4% &lt;15% at study end compared with in the DEFERRED group (RR = 0.11; 95% CI: 0.02, 0.60; p = 0.01). There was no statistical heterogeneity (see <a href="./references#CD010309-fig-00110" title="">Analysis 1.10</a>). In the 24 to 59 month age group, the proportion of children with CD4% &lt;15% in the IMMEDIATE group was lower than that in the DEFERRED group but the results were less precise and no longer statistically significant (RR = 0.40; 95% CI: 0.06, 2.52; p = 0.33, see <a href="./references#CD010309-fig-00208" title="">Analysis 2.8</a>). </p> </section> </section> <section id="CD010309-sec3-0028"> <h4 class="title">Growth parameters</h4> <section id="CD010309-sec4-0031"> <h5 class="title">Weight</h5> <p>In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, for all age groups, the mean weight gain per year was 2.2kg (SD: 1.1) in the IMMEDIATE group and 2.1kg (SD: 1.2) in the DEFERRED group, for a mean difference of 0.1kg (95% CI: ‐0.16, 0.36; p = 0.45; see <a href="./references#CD010309-fig-00111" title="">Analysis 1.11</a>). Median weight‐for‐age z scores at study end were available for all children in both trials. In the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial, the score in the IMMEDIATE group was ‐1.1 (IQR: ‐1.5 to ‐0.8) and in the DEFERRED group the score was ‐1.0 (IQR: ‐1.7 to 0.2). In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, the score was ‐1.27 (IQR: ‐1.78 to ‐0.39) in the IMMEDIATE group and ‐1.40 (IQR: ‐1.99 to ‐0.89) in the DEFERRED group. These scores indicate that growth was compromised in both groups in both trials (see <a href="./references#CD010309-fig-00112" title="">Analysis 1.12</a>). The change in median weight‐for‐age z score was calculated in <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a>. In the IMMEDIATE group, the change in median score was 0.26 (IQR: ‐2.00 to ‐0.75) which was a greater gain in weight than the median change in score of 0.04 (IQR: ‐0.28 to 0.34) in the DEFERRED group (p = 0.02 for difference). In a multivariate model, the authors found that the effect of group allocation remained significant (p = 0.01) after adjusting for baseline CD4% (&lt; 20% and ≥ 20%), age (&lt; 5 years and ≥ 5 years), haemoglobin level, and HIV RNA level. In the analysis of the 24 to 59 month age group in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, weight gain was similar in the IMMEDIATE and DEFERRED groups, with a mean difference of ‐ 0.03kg (95% CI: ‐0.25, 0.19; p = 0.79, see <a href="./references#CD010309-fig-00209" title="">Analysis 2.9</a>). </p> </section> <section id="CD010309-sec4-0032"> <h5 class="title">Height</h5> <p>In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, for all ages, the mean height gain per year was 5.4cm (SD: 1.4) in the IMMEDIATE group and 4.9cm (SD: 1.2) in the DEFERRED group, for a mean difference of 0.50cm (95% CI: 0.20, 0.80; p = 0.0009); see <a href="./references#CD010309-fig-00113" title="">Analysis 1.13</a>). Median height‐for‐age z scores at study end were available in both trials. In the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial, the score in the IMMEDIATE group was ‐1.4 (IQR: ‐2.0 to ‐0.8) and in the DEFERRED group the score was ‐0.8 (IQR: ‐1.3 to ‐0.4). In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, the score was ‐1.50 (IQR: ‐2.35 to ‐0.54) in the IMMEDIATE group and ‐1.73 (IQR: ‐2.42 to ‐0.95) in the DEFERRED group. These scores indicate that height was compromised in both groups in both trials (see <a href="./references#CD010309-fig-00114" title="">Analysis 1.14</a>). The change in median height‐for‐age z score was calculated in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial. In the IMMEDIATE group, the change in median score was 0.25 (IQR: ‐0.21 to ‐0.69) in the IMMEDIATE group and the median change in score was ‐0.02 (IQR: ‐0.40 to 0.34) in the DEFERRED group (p = 0.004 for difference). The children in the IMMEDIATE group thus gained more height than those in the DEFERRED group. In an adjusted analysis, the authors found that the effect of group allocation remained significant (p = 0.002) after adjusting for baseline CD4% (&lt; 20% and ≥ 20%), age (&lt; 5 years and ≥ 5 years), haemoglobin level, and HIV RNA level. In the analysis of the 24 to 59 month age group in <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a>, mean height gain was slightly greater in the IMMEDIATE group compared to the DEFERRED group, with a mean difference of 0.3cm (95%CI: ‐0.28, 0.88; p = 0.31; see <a href="./references#CD010309-fig-00210" title="">Analysis 2.10</a>). </p> </section> </section> <section id="CD010309-sec3-0029"> <h4 class="title">Neurological parameters</h4> <p>In the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial, the neurodevelopment sub‐study was phased in after the main study had started and baseline Beery Visual Motor Integration assessment was only performed in 71 children. The mean baseline scores for children of all age groups in the IMMEDIATE and DEFERRED groups were 81.5 (SD: 17.2) and 87.1 (SD: 14.4) respectively. There was no statistically significant difference between the groups at study end (week 144). The mean difference was ‐1.40 (95% CI: ‐4.70, 1.90; p = 0.41; see <a href="./references#CD010309-fig-00115" title="">Analysis 1.15</a>). The authors report that for the 71 children who had a baseline assessment, the mean difference in Beery standard score change from baseline from week 0 to 144 between IMMEDIATE and DEFERRED arms was –4·37 (–12·00 to 3·26; p =0·26). In the subgroup analysis, the Beery Visual Motor Integration score was available for 42 and 40 of the children aged 24 to 59 months in the IMMEDIATE and DEFERRED group respectively. Again, there was no statistically significant difference between the groups at study end. The mean difference was 2.3 (95% CI: ‐4.37, 8.97; p = 0.50; see <a href="./references#CD010309-fig-00211" title="">Analysis 2.11</a>). </p> </section> <section id="CD010309-sec3-0030"> <h4 class="title">Adverse events</h4> <p>The <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial reported on the proportion of children of all age groups with adverse events, but did not provide data on the severity of the events. All children in the DEFERRED group and 92% of those in the IMMEDIATE group experienced an adverse event (RR = 0.92; 95% CI: 0.80, 1.07; p = 0.29). Both trials reported on the proportion of children of all age groups with adverse events related to cART. Children in the IMMEDIATE group were more likely to develop cART‐related adverse events than those in the DEFERRED group but this was not statistically significant (RR = 1.87; 95% CI: 0.77, 4.51; p = 0.17) and there was little statistical heterogeneity (Chi² = 0.96, df = 1; p = 0.33; I² = 0%). The proportion of children in the 24 to 59 month age group in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial with ART‐related Grade 3 or 4 events was lower in the IMMEDIATE group than in the DEFERRED group (RR = 0.48; 95%CI: 0.04, 5.11; p = 0.54; see <a href="./references#CD010309-fig-00212" title="">Analysis 2.12</a>). </p> </section> <section id="CD010309-sec3-0031"> <h4 class="title">GRADE ASSESSMENTS</h4> <p>GRADE assessments were conducted for all outcomes where data was available to enter into GRADEPro. For the Summary of Findings tables we selected seven outcomes per comparison based on what is most important to patients. </p> <p>Overall, the quality of evidence observed in the two trials was low or very low. For evidence for initiation of cART in all age groups, we down‐graded the evidence for indirectness (as the age group was not specific to the population group of interest) and for serious or very serious imprecision. The <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial was well‐conducted with the sample size planned to be powered for the primary outcome of AIDS‐free survival; however, due to the low number of events and slow disease progression, the study was ultimately under‐powered to adequately assess this outcome. Note that we did not create a Summary of Findings Table for the outcome of AIDS‐free survival. For all other outcomes, the sample size was considered small and for most outcomes the event rate was extremely small, leading to imprecision in the results. This remained when combined with the data from the <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a> trial as the trial added only 43 children to the total. See <a href="./full#CD010309-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>For the post hoc subgroup analysis of ages 24 to 59 months, we did not downgrade for indirectness as the population was specific to the question of this review. However, as this was a post hoc analysis, the risk of selection bias resulted in downgrading for risk of bias. We continued to downgrade for very serious imprecision due to the small sample size, the low event rate and wide confidence intervals. See <a href="./full#CD010309-tbl-0002">summary of findings Table 2</a>. </p> <p>For the evidence arising from the observational study (<a href="./references#CD010309-bbs2-0003" title="YotebiengM , VanRieA , MoultrieH , ColeSR , AdimoraA , BehetsF , et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (London, England)2010;24(9):1341‐9. [PUBMED: 20559039] ">Yotebieng 2010</a>), the quality of evidence was rated as very low for all outcomes. We downgraded for risk of bias due to a residual risk of selection bias: we cannot be certain that the IPTC weighting of marginal structural models removed all bias. As the study included children aged one to 15 years we downgraded for indirectness. Due to the low number of events, we downgraded for serious imprecision. </p> <p>Using the GRADE approach, we are very uncertain of the effect estimates overall.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010309-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010309-sec1-0006"></div> <section id="CD010309-sec2-0010"> <h3 class="title" id="CD010309-sec2-0010">Summary of main results</h3> <p>Our review identified limited evidence from two small randomised controlled trials evaluating the effects of initiating cART in children aged one to 12 years immediately at CD4% between 15 and 25%, compared with deferring cART until pre‐defined immunological and clinical thresholds. No differences in outcomes were noted between the randomised groups. </p> <p>We identified a single cohort study which compared delaying cART in HIV‐infected children co‐infected with TB with initiating cART soon after commencing TB treatment. Delaying cART initiation to later than 15 days after commencing TB treatment was protective against death but this effect was reduced at 30 days, and potentially harmful if cART was deferred beyond 60 days. </p> <p>None of the studies exclusively included children within the specific focus age of two to five years. </p> </section> <section id="CD010309-sec2-0011"> <h3 class="title" id="CD010309-sec2-0011">Overall completeness and applicability of evidence</h3> <p>The trials included in this review did not evaluate the effects of immediate or deferred initiation of cART in children aged two to five years, but in the broader age group of one to 12 years. Although we were able to obtain age‐specific data from the two trials, the evidence generated from these post hoc sub‐group analyses is less robust given that randomisation did not take place within the age‐specific sub‐group. Stronger evidence would be gained from replicating trials within the specific age group, but it is unlikely that new trials will assess this in future. Antiretroviral treatment has been indicated for all HIV‐positive infants and children less than two years of age since 2010 (<a href="./references#CD010309-bbs2-0029" title="World Health Organization. Antiretroviral therapy of HIV infection in infants and children: towards universal access: recommendations for a public health approach [2010 revision]. 2010; Vol. http://whqlibdoc.who.int/publications/2010/9789241599801_eng.pdf (Accessed 29 July 2012). ">WHO 2010b</a>). As cART becomes increasingly available across the world, identification and recruitment into trials of children aged two or more may no longer be feasible. </p> <p>The evidence generated from the two trials and the single included cohort study arise from resource‐constrained settings affected by the HIV/AIDS epidemic (Thailand, Cambodia and South Africa). The participants in the trials are therefore likely to be representative of HIV‐infected children living in poverty. However, the children and their carers were from urban settings and in this respect the results may not be generalizable to those children and their carers living in impoverished rural areas. </p> </section> <section id="CD010309-sec2-0012"> <h3 class="title" id="CD010309-sec2-0012">Quality of the evidence</h3> <p>The quality of the methodological conduct for the larger <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial was judged to be high and the risk of bias was likely to be low to moderate for both trials overall. However, when using the GRADE approach to assess the overall quality of the evidence generated in the review, the quality of the evidence was rated as low or very low. This was due to the indirectness of the included population and the marked imprecision present in the results. Imprecision was driven largely by the small sample size and low event rates. The sample size of the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial was powered for the primary outcome of AIDS‐free survival; however, due to the low number of events and slow disease progression, the study was ultimately under‐powered to adequately assess this and this reduced the quality of the evidence. </p> <p>In the <a href="./references#CD010309-bbs2-0003" title="YotebiengM , VanRieA , MoultrieH , ColeSR , AdimoraA , BehetsF , et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (London, England)2010;24(9):1341‐9. [PUBMED: 20559039] ">Yotebieng 2010</a> cohort study, close attention was paid to confounding and the authors addressed this via weighted adjusted analyses which included adjusting for time‐dependent level of immuno‐suppression, viral load, weight‐for‐age Z score and age at TB treatment initiation. Despite this, the quality of evidence generated by a single cohort study was appraised in GRADE as providing very low evidence due to selection bias (lack of randomisation), indirectness and imprecision. </p> </section> <section id="CD010309-sec2-0013"> <h3 class="title" id="CD010309-sec2-0013">Potential biases in the review process</h3> <p>Possible selection biases in the review process were minimised by using a comprehensive search strategy to identify studies and, wherever possible, independently selecting and appraising the studies. In addition to searching journal and conference electronic databases, we conducted hand‐searching of several important conference abstract books, including the <i>International Workshop on HIV Pediatrics</i> and recent relevant conferences not yet included in the electronic databases. We contacted several authors of conference abstracts to confirm whether the data in their abstract corresponded to subsequent journal articles or to assess whether the reported data was eligible for inclusion in this review. it is unlikely that important trials have been missed given the high‐profile nature of the topic and the close partnership established with agencies and organizations working in this area. </p> <p>Data extraction was done independently by one author and then checked by a second author. Ideally all data extraction should be conducted independently by two authors; however, this was not feasible given the time constraints of the rapid review process. The results were presented at a WHO Guidelines Committee Meeting in December 2012 providing a further check of the data by experts and investigators familiar with the data, thereby reducing any potential measurement bias introduced by a single author conducting data extraction. </p> <p>We conducted several sensitivity analyses using different statistical models and estimates of effect. This was especially important to do for several of the analyses which were limited by small denominators and few events (<a href="./references#CD010309-bbs2-0016" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available from www.cochrane‐handbook.org. ">Higgins 2009</a>). Conducting sensitivity analyses allowed us to interrogate the data closely and consider the robustness of the findings. </p> </section> <section id="CD010309-sec2-0014"> <h3 class="title" id="CD010309-sec2-0014">Agreements and disagreements with other studies or reviews</h3> <p>We were unable to identify any other studies or reviews addressing the question of when to start cART in children aged 24 to 59 months. Lewis <i>et al</i> monitored 127 children enrolled in the Paediatric European Network for the Treatment of AIDS 5 and found that initiation of cART at higher CD4 counts may improve long term immune reconstitution and may potentially reduce the so‐called 'non‐AIDS' morbidity developed as a result of immune activation without causing harm or significantly increasing drug‐related toxicity (<a href="./references#CD010309-bbs2-0017" title="LewisJ , WalkerAS , CastroH , DeRossiA , GibbDM , GiaquintoC , KleinN , CallardR . Age and CD4 Count at Initiation of Antiretroviral Therapy in HIV‐Infected Children: Effects on Long‐term T‐Cell Reconstitution. J Infect Dis2011;205:548‐56. ">Lewis 2011</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010309-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram of database yields using the RCT string" data-id="CD010309-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram of database yields using the RCT string</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD010309-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD010309-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 1 Death." data-id="CD010309-fig-00101" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 1 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 2 CDC Category C disease (number of children)." data-id="CD010309-fig-00102" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 2 CDC Category C disease (number of children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 3 CDC Category B disease (numbers of children) Relative Risk." data-id="CD010309-fig-00103" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 3 CDC Category B disease (numbers of children) Relative Risk. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 4 CDC Category B disease (numbers of children) Peto Odds Ratio." data-id="CD010309-fig-00104" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 4 CDC Category B disease (numbers of children) Peto Odds Ratio. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 5 Pulmonary TB (clinically diagnosed)." data-id="CD010309-fig-00105" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 5 Pulmonary TB (clinically diagnosed). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00106"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IMMEDIATE (time on ART before events)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DEFERRED (time from enrolment to events)</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ananworanich 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 (IQR: 48 ‐ 72) weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nil</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PREDICT 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9 (IQR: 4 ‐ 30) weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57 (IQR: 34 ‐ 101) weeks</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 6 Median time before development of CDC B or C event. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00106">Navigate to figure in review</a></div> </div> <div class="figure" id="CD010309-fig-00107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 7 Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml." data-id="CD010309-fig-00107" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 7 Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00108"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IMMEDIATE</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DEFERRED</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>P value</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ananworanich 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 31 (24 ‐ 39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median (IQR): 23 (17 ‐ 31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.032</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 8 Median CD4% at study end. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00108">Navigate to figure in review</a></div> </div> <div class="figure" id="CD010309-fig-00109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 9 Mean CD4% at week 144." data-id="CD010309-fig-00109" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 9 Mean CD4% at week 144. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 10 Proportion of children with CD4% &lt; 15% at study end." data-id="CD010309-fig-00110" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 10 Proportion of children with CD4% &lt; 15% at study end. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 11 Mean weight gain per year in kg." data-id="CD010309-fig-00111" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 11 Mean weight gain per year in kg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00112"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IMMEDIATE</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DEFERRED</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ananworanich 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.1 (IQR: ‐1.5 to ‐0.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.0 (IQR: ‐1.7 to 0.2)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PREDICT 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.27 (IQR: ‐1.78 to ‐.0.39)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.40 (IQR: ‐1.99 to ‐0.89)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 12 Median weight‐for‐age Z score at study end (134 ‐ 144 weeks). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00112">Navigate to figure in review</a></div> </div> <div class="figure" id="CD010309-fig-00113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 13 Mean height gain per year in cm." data-id="CD010309-fig-00113" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 13 Mean height gain per year in cm. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00114"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>IMMEDIATE</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>DEFERRED</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ananworanich 2008</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.4 (IQR: ‐2.0 to ‐0.8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.8 (IQR: ‐1.3 to ‐0.4)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PREDICT 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.50 (IQR: ‐2.35 to ‐.0.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.73 (IQR: ‐2.42 to ‐0.95)</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 14 Median height‐for‐age Z score at study end (134 ‐ 144 weeks). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00114">Navigate to figure in review</a></div> </div> <div class="figure" id="CD010309-fig-00115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 15 Mean standardized score on Beery VMI at 144 weeks." data-id="CD010309-fig-00115" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 15 Mean standardized score on Beery VMI at 144 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 16 Proportion of children with adverse events." data-id="CD010309-fig-00116" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 16 Proportion of children with adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 17 Proportion of children with ART‐related adverse events." data-id="CD010309-fig-00117" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 IMMEDIATE versus DEFERRED initiation of ART all ages (RCT), Outcome 17 Proportion of children with ART‐related adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 1 Death." data-id="CD010309-fig-00201" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 1 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 2 CDC Category C disease (number of children)." data-id="CD010309-fig-00202" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 2 CDC Category C disease (number of children). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 3 CDC Category B disease (numbers of children) Relative Risk." data-id="CD010309-fig-00203" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 3 CDC Category B disease (numbers of children) Relative Risk. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 4 CDC Category B disease (numbers of children) Peto Odds Ratio." data-id="CD010309-fig-00204" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 4 CDC Category B disease (numbers of children) Peto Odds Ratio. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00205"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 5 Pulmonary TB (clinically diagnosed)." data-id="CD010309-fig-00205" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 5 Pulmonary TB (clinically diagnosed). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00205">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00206"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 6 Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml." data-id="CD010309-fig-00206" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 6 Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00206">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00207"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 7 Mean CD4% at week 144." data-id="CD010309-fig-00207" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 7 Mean CD4% at week 144. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00207">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00208"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 8 Proportion of children with CD4% &lt; 15% at study end." data-id="CD010309-fig-00208" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 8 Proportion of children with CD4% &lt; 15% at study end. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00208">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00209"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 9 Mean weight gain per year in kg." data-id="CD010309-fig-00209" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 9 Mean weight gain per year in kg. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00209">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00210"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 10 Mean height gain per year in cm." data-id="CD010309-fig-00210" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 10 Mean height gain per year in cm. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00210">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00211"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 11 Mean standardized score on Beery VMI at 144 weeks." data-id="CD010309-fig-00211" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 11 Mean standardized score on Beery VMI at 144 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00211">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00212"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-002-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-002-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 12 Proportion of children with ART‐related Grade 3 or 4 adverse events." data-id="CD010309-fig-00212" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT), Outcome 12 Proportion of children with ART‐related Grade 3 or 4 adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00212">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-002-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00301"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 ADJUSTED/WEIGHTED EARLY vs DEFERRED initiation of ART in children with TB and HIV, Outcome 1 Death." data-id="CD010309-fig-00301" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 ADJUSTED/WEIGHTED EARLY vs DEFERRED initiation of ART in children with TB and HIV, Outcome 1 Death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00301">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010309-fig-00302"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/urn:x-wiley:14651858:media:CD010309:CD010309-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_t/tCD010309-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 ADJUSTED/WEIGHTED EARLY vs DEFERRED initiation of ART in children with TB and HIV, Outcome 2 Virologic suppression." data-id="CD010309-fig-00302" src="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 ADJUSTED/WEIGHTED EARLY vs DEFERRED initiation of ART in children with TB and HIV, Outcome 2 Virologic suppression. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-fig-00302">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/media/CDSR/CD010309/image_n/nCD010309-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD010309-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged one to 12 years old</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> HIV‐positive, treatment‐naive children aged one to 12 years old <br/> <b>Settings:</b> Thailand and Cambodia<br/> <b>Intervention:</b> IMMEDIATE initiation of cART<br/> <b>Comparison:</b> DEFERRED initiation of cART </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> DEFERRED initiation of cART</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> IMMEDIATE initiation of cART </b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/> (0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 3</b> <br/> (0.12 to 73.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>343<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CDC Category C disease (number of children)</b> <br/> Follow‐up: 144 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>12 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>18 per 1000</b> <br/> (3 to 105) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.5</b> <br/> (0.25 to 8.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>343<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CDC Category B disease (numbers of children) Peto Odds Ratio</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>189 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>141 per 1000</b> <br/> (83 to 225) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.7</b> <br/> (0.39 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>343<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml (Copy)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>815 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>783 per 1000</b> <br/> (685 to 889) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> <br/> (0.84 to 1.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>238<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Weight gain per year in kg</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight gain per year in kg in the intervention groups was<br/> <b>0.1 higher</b> <br/> (0.16 lower to 0.36 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Height gain per year in cm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean height gain per year in cm in the intervention groups was<br/> <b>0.5 higher</b> <br/> (0.2 to 0.8 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>300<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Standardized score on Beery VMI at 144 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean standardized score on Beery VMI at 144 weeks in the intervention groups was<br/> <b>1.4 lower</b> <br/> (4.7 lower to 1.9 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>272<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2,6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Patient or population:</b> </p> <p>HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)<br/> <b>Settings:</b> Thailand and Cambodia<br/> <b>Intervention:</b> IMMEDIATE initiation of cART<br/> <b>Comparison:</b> DEFERRED initiation of cART </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comments</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Assumed risk</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Corresponding risk</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>DEFERRED initiation of cART</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> As the trials were open‐label neither participants nor caregivers were blinded. However outcome assessors were blinded in the PREDICT trial. Attrition was low in both trials. Information on the randomisation procedure was lacking in <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a>. However, given that this trial is relatively small, we judged the overall risk of bias to be low for the two trials together.<br/> <sup>2</sup> The age group included in the trials ranged from one year to 12 years old and did not focus on the specific population focus of this review: ages 24 to 59 months.<br/> <sup>3</sup> The confidence interval is very large and the event rate very low. There was only one death.<br/> <sup>4</sup> The event rate was very low and the overall sample size is also small.<br/> <sup>5</sup> The trials reported conflicting results and there was substantial unexplained heterogeneity.<br/> <sup>6</sup> The results are from only one trial so consistency cannot be adequately gauged.<br/> <sup>7</sup> The sample size is less than 400 and according to the GRADE approach imprecision is present when continuous outcomes are compared in samples less than 400. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged one to 12 years old</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD010309-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subgroup analysis: IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SUBGROUP ANALYSIS: IMMEDIATE initiation of cART compared to DEFERRED initiation of cART in HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)<br/> <b>Settings:</b> Thailand and Cambodia<br/> <b>Intervention:</b> SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>0 per 1000</b> <br/> (0 to 0) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 2.88</b> <br/> (0.12 to 68.88) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CDC Category C disease (number of children)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>16 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>15 per 1000</b> <br/> (1 to 236) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> <br/> (0.06 to 14.87) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CDC Category B disease (numbers of children) Peto Odds Ratio</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>239 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>167 per 1000</b> <br/> (70 to 355) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.64</b> <br/> (0.24 to 1.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>789 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>876 per 1000</b> <br/> (679 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.11</b> <br/> (0.86 to 1.43) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean weight gain per year in kg</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean weight gain per year in kg in the intervention groups was<br/> <b>0.03 lower</b> <br/> (0.25 lower to 0.19 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean height gain per year in cm</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean height gain per year in cm in the intervention groups was<br/> <b>0.3 higher</b> <br/> (0.28 lower to 0.88 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>94<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mean standardized score on Beery VMI at 144 weeks</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean standardized score on Beery VMI at 144 weeks in the intervention groups was<br/> <b>2.3 higher</b> <br/> (4.37 lower to 8.97 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>82<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>OR:</b> Odds ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> This is a subgroup analysis within each of the Ananworanich 2009 and <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trials. Randomisation was not conducted within the sub‐group. For <a href="./references#CD010309-bbs2-0001" title="AnanworanichJ , KosalaraksaP , SiangphoeU , EngchanilC , PancharoenC , LumbiganonP , et al. A feasibility study of immediate versus deferred antiretroviral therapy in children with HIV infection. AIDS research and therapy2008;5:24. [PUBMED: 18957095] ">Ananworanich 2008</a>, the proportion of children aged 24 to 59 months in the IMMEDIATE group was 46% (11/24) and in the DEFERRED group it was 89% (17/19). This differential could introduce selection bias.<br/> <sup>2</sup> The sample size of the two subgroups of age‐specific data for 24 to 59 months is 122 and the event rate is very small. The confidence interval is very large.<br/> <sup>3</sup> Randomisation was not conducted within the sub‐group. In the PREDICT trial, the proportion of the overall sample in the subgroup in the IMMEDIATE group was 32% (48/150) and in the DEFERRED group it was 31% (46/150). Although this is balanced, we cannot exclude the possibility of selection bias as this analysis was conducted post hoc.<br/> <sup>4</sup> The sample size of the subgroup of age‐specific data for 24 to 59 months in the <a href="./references#CD010309-bbs2-0002" title="WongsawatJ , PuthanakitT , KanjanavanitS , HansudewechakulR , NgampiyaskulC , KerrSJ , et al. CD4 cell count criteria to determine when to initiate antiretroviral therapy in human immunodeficiency virus‐infected children. The Pediatric infectious disease journal2010;29(10):966‐8. [PUBMED: 20418798] ">PREDICT 2012</a> trial is 94 and the event rate is very small. The confidence interval is large.<br/> <sup>5</sup> Randomisation was not conducted within the sub‐group. In the PREDICT trial, the proportion of the overall sample in the subgroup in the IMMEDIATE group was 32% (48/150) and in the DEFERRED group it was 31% (46/150). In this comparison (children on ART with HIV‐RNA &lt; copies/ml) only those children on ART in the DEFERRED group (19/150) were included so the proportions are very imbalanced.<br/> <sup>6</sup> The sample size of the two subgroups of age‐specific data for 24 to 59 months is small (N = 67). Imprecision is likely to be present.<br/> <sup>7</sup> The sample size is very small. In the GRADE system, imprecision is likely to be present when continuous outcomes are compared in samples less than 400. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subgroup analysis: IMMEDIATE initiation of cART compared to DEFERRED initiation of cART for HIV‐positive, treatment‐naive children aged 24 to 59 months (2 to 5 years old)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/full#CD010309-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010309-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IMMEDIATE versus DEFERRED initiation of ART all ages (RCT)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.12, 73.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 CDC Category C disease (number of children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [0.25, 8.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 CDC Category B disease (numbers of children) Relative Risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.14, 14.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 CDC Category B disease (numbers of children) Peto Odds Ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.39, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pulmonary TB (clinically diagnosed) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.21 [0.52, 19.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Median time before development of CDC B or C event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.84, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Median CD4% at study end <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mean CD4% at week 144 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.40 [6.83, 9.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Proportion of children with CD4% &lt; 15% at study end <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.02, 0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mean weight gain per year in kg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>299</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.16, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Median weight‐for‐age Z score at study end (134 ‐ 144 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mean height gain per year in cm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.20, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Median height‐for‐age Z score at study end (134 ‐ 144 weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mean standardized score on Beery VMI at 144 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐4.70, 1.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Proportion of children with adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.80, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Proportion of children with ART‐related adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>343</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [0.77, 4.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">IMMEDIATE versus DEFERRED initiation of ART all ages (RCT)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010309-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.88 [0.12, 68.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 CDC Category C disease (number of children) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.06, 14.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 CDC Category B disease (numbers of children) Relative Risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.24, 3.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 CDC Category B disease (numbers of children) Peto Odds Ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.29, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pulmonary TB (clinically diagnosed) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.19, 7.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Proportion of children on ART with HIV‐RNA &lt; 50 copies/ml <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.86, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mean CD4% at week 144 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.90 [2.74, 9.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Proportion of children with CD4% &lt; 15% at study end <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.06, 2.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Mean weight gain per year in kg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.25, 0.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mean height gain per year in cm <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.28, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mean standardized score on Beery VMI at 144 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [‐4.37, 8.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Proportion of children with ART‐related Grade 3 or 4 adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.04, 5.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SUBGROUP ANALYSIS: IMMEDIATE versus DEFERRED initiation of ART 24 to 59 months (RCT)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010309-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">ADJUSTED/WEIGHTED EARLY vs DEFERRED initiation of ART in children with TB and HIV</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 &gt; 15 DAYS vs =&lt; 15 DAYS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.52, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 &gt; 30 DAYS vs =&lt; 30 DAYS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>494</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.49, 1.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 &gt; 60 DAYS vs =&lt; 60 DAYS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.36, 4.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Virologic suppression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 &gt; 15 DAYS vs =&lt; 15 DAYS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.76, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 &gt; 30 DAYS vs =&lt; 30 DAYS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.74, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 &gt; 60 DAYS vs =&lt; 60 DAYS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.64, 1.10]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">ADJUSTED/WEIGHTED EARLY vs DEFERRED initiation of ART in children with TB and HIV</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010309.pub2/references#CD010309-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010309.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010309-note-1207">Español</a> </li> <li class="section-language"> <a class="" href="fr#CD010309-note-1206">Français</a> </li> <li class="section-language"> <a class="" href="pt#CD010309-note-1205">Português</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010309\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010309\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010309\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010309\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010309\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010309.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010309.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010309.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010309.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010309.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726450952"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010309.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726450956"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010309.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e93ed8cc89368',t:'MTc0MDcyNjQ1MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 